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ABSTRACT
Cardiac and Mitochondrial Impacts of Acute Pulmonary Xenobiotic Exposure
Cody Edward Nichols
With every breath, we breathe in foreign materials, xenobiotic particles, which once inside these
particles can interact with our tissues and influence the systems within. Airborne xenobiotic particles
classically refer to ambient particulate matter (PM), but with technological advancement and the
flourishing of nanotechnology, engineered nanomaterials (ENMs) have become entwined in the
definition. Because the term xenobiotic particles encompasses particles with a broad range of size,
shapes and chemical composition, definition of the properties that induce toxicity can be difficult, yet
crucial to understand and predicting which of these characteristics is capable of inducing toxicity. This
concept is crucial as nanotechnology moves forward and continues to introduce particles with new,
unique properties. Beginning to identify the health impacts of xenobiotic particles it is important to
consider ambient air pollution and the solid fraction of this mixture, particulate matter (PM). PM itself is
a non-uniform, composite particle containing particles ranging in size and chemical composition.
Further, PM composition can vary throughout the US and has been shown to differentially affect
cardiovascular susceptibilities and outcomes. Within the Appalachian region, coal is a multi-billion dollar
industry and comes in two forms: underground and surface mining. Surface mining is growing
throughout the region due to its less labor-intensive methods, which employs large machinery to
remove the soil and rock from on top of mineral deposits. One form of surface mining utilizes explosives
to remove this overburden, mountaintop removal mining (MTM). Even though the mining companies
attempt to abate fugitive dust, the populations surrounding these mining operations have a higher
incidence of chronic cardiovascular disease mortality rates. This suggests that the PM created by MTM
(PMMTM) may induce cardiac stress leading to cardiovascular disease. Nanotechnology is rapidly growing
into a multi-billion dollar industry and is already incorporated into consumer products including
everything from sporting equipment and food storage to personal care products and biomedical
applications. With the rapid growth of nanotechnology, the toxicological impact of the ENMs driving
expansion cannot keep pace with the advancement. Nano-sized particles differ in their physicochemical
properties as compared to their micron-sized counterparts and while these properties imbue them with
the novel applications driving nanotechnology, they may also be driving toxicological impacts. ENMs are
carefully and methodically produced in particles of varying size, shape and chemical composition to
accomplish different consumer-based end-products. Multi-walled carbon nanotubes (MWCNT) are a
rapidly growing ENM with uniquely strong and electrical properties making it useful in everything from
sporting equipment to electronics. Titanium dioxide (nano-TiO2) is a relatively inert ENM widely used as
a photocatalyst and pigment in paints and personal care products. Exposure to these materials has
shown adverse pulmonary and cardiovascular effects but the cardiac functional impacts following
exposure have not been well characterized. Further, the subcellular cardiac mechanisms impacted by
xenobiotic exposure have not been well defined. The mitochondrion may be a target of xenobiotic
exposure propagating toxicity. Within the cardiomyocyte, mitochondrial analyses are further
complicated by the presence of spatially and biochemically distinct subpopulations of mitochondria: the
subsarcolemmal (SSM) and interfibrillar (IFM) mitochondria. The SSM sit below the sarcolemma while
the IFM reside within the contractile apparatus. The goal of the current studies was to investigate the
cardiac and mitochondrial impacts following an acute pulmonary xenobiotic exposure. To complete this
goal, we utilized pulmonary exposure techniques, state of the art echocardiographic assessment, and
mitochondrial functional analyses following xenobiotic exposure. Following a pulmonary exposure to
PMMTM, we identified a significant decrease in cardiac ejection fraction and fractional shortening

concomitant with an increase in cardiac apoptosis. Investigation into the source of apoptotic signaling
suggested the mitochondria as central into apoptotic initiation and leads to both SSM and IFM
respiratory dysfunction. Similarly, when we exposed animals to MWCNT we identified cardiac
dysfunction developing after SSM and IFM respiratory dysfunction. Yet, further investigation into the
mitochondrial affects identified that the IFM produced more reactive oxygen species (ROS) following
exposure. Finally, following exposure to nano- TiO2 cardiac diastolic dysfunction was observed indicative
of restrictive filling during diastole. Following exposure, there was a significant decrease in
mitochondrial respiratory function and an increase in ROS production and damage in the IFM. To
attenuate the mitochondrial ROS production and damage leading to cardiac dysfunction, we utilized a
novel transgenic animal overexpressing the antioxidant mitochondrial phospholipid hydroperoxide
glutathione peroxidase (mPHGPx). MPHGPx has been previously shown to be efficient in protecting the
inner mitochondrial membrane (IMM) from ROS damage and preserve the mitochondrion’s function and
proteome. The IMM is essential to protect as the complexes within the mitochondrial electron transport
chain (ETC) reside within the locale. Overexpressing mPHGPx attenuated mitochondrial ROS production
and damage as well as the cardiac diastolic dysfunction observed following exposure to nano-TiO2.
These findings support that acute xenobiotic exposure can negatively impact cardiac and mitochondrial
function. Overall, this data also suggests that the xenobiotic particles with different sizes and chemical
composition can differentially impact these extrapulmonary effects. Further, these studies suggest that
ROS plays a significant role in the induction of mitochondrial dysfunction following exposure to
xenobiotic exposure. Better understanding the physicochemical properties that induce cardiac and
mitochondrial dysfunction is vital in preserving and protecting the heart from xenobiotic induced
damage.
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SPECIFIC AIMS

Inhalation of xenobiotic particles, foreign particles that gain access to our bodies, is
universal, yet differences in particle size, shape and composition exist between different
environments. Particulate matter exposures, which occur within our everyday environment, are
a non-specific agglomerate of particles making investigation into effects translationally relevant
yet the broad range of constituent size, shape and chemical composition makes causality of
each of these characteristics on human health difficult. Distilling this particulate into particles
with uniform characteristics allows us to better elucidate the impact of each characteristic on
health. Realizing impacts of particle characteristics is important to diminish the impact these
exposures have on human health and expedite the process of toxicological assessment when
new materials are introduced. One rapidly expanding area of material research and production
is in engineered nanomaterials. These materials, while all less than one-hundred nanometers in
at least one dimension, have different shapes and chemical composition making predictions into
the human health effects difficult without first realizing the impacts these characteristics
themselves have on health.
Inhalation exposure to particulates of varying size, shape and composition has shown
adverse health effects throughout the body with the cardiopulmonary system being specifically
targeted (1). While cardiovascular effects have been well recognized (3, 7, 10), the attributing
mechanisms and influence of subcellular locales have not been well characterized. Due to its
central role in energy production and the formation of reactive oxygen species (ROS), the
mitochondrion has been identified as central in the etiology of many cardiovascular pathologies
and may be a target of environmental toxicants (4, 6). Studies investigating the impacts of
environmental toxicants on mitochondrial function are limited but have highlighted the
mitochondrion’s role in ROS production and systemic ROS damage as central to the toxicity of
various particulates (5, 9, 11). Because the mitochondrion is a primary source of ROS, its
xv

proteins, lipids and DNA are targets of damage from excess ROS (2). Increased ROS damage
can lead to mitochondrial dysfunction and the induction of apoptosis through the mitochondrion
(8). Yet, no studies have attempted to elucidate the role of mitochondrial ROS production and
function within the heart following a pulmonary xenobiotic exposure. Within the cardiomyocyte,
mitochondrial analyses are further complicated by the presence of two spatially and
biochemically distinct subpopulations: the subsarcolemmal mitochondria (SSM), present
beneath the sarcolemma, and the interfibrillar mitochondria (IFM), found between the contractile
apparatus. Currently a gap in knowledge exists regarding our understanding of cardiac
impacts following pulmonary exposures to particulates of varying size, shape and composition
and the role of ROS in these cardiovascular effects.

My long-term goal is to identify and alleviate mechanisms contributing to adverse
cardiac effects associated with a pulmonary xenobiotic exposure. By identifying mechanisms in
a composite xenobiotic particulate and then moving to particles of uniform size, shape and
chemical composition I will be able to better elucidate the role physiochemical properties
contribute to the adverse cardiac effects associated with a pulmonary exposure. My objectives
are: [1] to elucidate the impact a regionally-specific composite particulate matter xenobiotic
pulmonary exposure has on cardiac apoptosis and mitochondrial dysfunction [2] to investigate
the influence of a pulmonary exposure to carbon-based engineered nanomaterials on
mitochondrial oxidative stress and [3] to evaluate the impact ROS damage plays in cardiac and
mitochondrial dysfunction following a pulmonary exposure to an engineered nanomaterial using
a mitochondrial therapy (mitochondrial phospholipid hydroperoxide glutathione peroxidase;
mPHGPx). My central hypothesis is that acute pulmonary exposure to particulates of
varying size, shape and chemical composition differentially elicits increased cardiac
oxidative stress triggering apoptosis and eliciting cardiac mitochondrial dysfunction,
which is subject to spatial influence, contributing to cardiac dysfunction following
xvi

exposure. My rationale for the proposed research is based on the finding that particulate
matter increases cardiac susceptibility and increased mortality from chronic cardiovascular
disease. Also, this research is based on the findings that mitochondria may be targets of
engineered nanomaterial exposure. My central hypothesis is based on preliminary data showing
cardiac and mitochondrial dysfunction following pulmonary xenobiotic exposures. I will test my
central hypothesis by pursuing the following Specific Aims:

Specific Aim I: Elucidate the impact of a pulmonary exposure of mountaintop mining
particulate matter on cardiac mitochondrial ROS production leading to apoptosis and
mitochondrial dysfunction.
To address Specific aim I, I will utilize a translationally relevant particulate collected around
an active mountaintop mine, immunostaining and mitochondrial functional assessments in
isolated subsarcolemmal (SSM) and interfibrillar (IFM) subpopulations. I will test my
working hypothesis that acute mountaintop mining particulate matter pulmonary exposure
increases mitochondrial apoptosis and decreases mitochondrial function in spatially-distinct
cardiac mitochondria, with effects most pronounced in the SSM.

Specific Aim II: Investigate the impact of acute pulmonary exposure to carbon-based
engineered nanomaterials on cardiac and mitochondrial function.
In order to address Specific aim II, I will utilize isolated cardiac mitochondrial SSM and IFM
subpopulations for fluorescent and spectrophotometric assays for ROS production and
mitochondrial function. I will test my working hypothesis that carbon-based engineered
nanomaterial dose will differentially elicit mitochondrial ROS production negatively impacting
the function of spatially-distinct mitochondria, with effects most pronounced in the IFM.

xvii

Specific Aim III: Evaluate the cardioprotective efficacy of a mitochondrial-targeted
antioxidant

therapeutic

(mitochondrial

phospholipid

hydroperoxide

glutathione

peroxidase; mPHGPx) following engineered nanomaterial exposure.
To address Specific aim III, I will utilize WVU’s unique inhalation chamber, a commercially
available titanium dioxide and a novel antioxidant overexpressing transgenic mouse. I will
test my working hypothesis that overexpression of a mitochondrially-targeted antioxidant,
mPHGPx, will protect the heart from increased oxidative stress contributing to spatiallydistinct mitochondrial dysfunction following nano-Titanium dioxide exposure, that is most
pronounced in the IFM.

This work is innovative because it is the first in vivo study to suggest a mitochondrial
mechanism, with a spatial element, to be central in the cardiac dysfunction presented by
pulmonary xenobiotic exposure. The expected outcomes will provide insight into the role of
ROS in mitochondrial mechanisms impacting the cardiovascular system following an acute
pulmonary xenobiotic exposure. Using particles of different size, shape and chemical
composition I expect to better understand how these various properties impact the mechanisms
of ROS production and damage following exposure. Also by utilizing a mitochondrially-targeted
antioxidant I expect to attenuate oxidative damage and better understand the impacts of ROS
on cardiac function following acute pulmonary xenobiotic exposures. To improve cardiovascular
health of all Americans and decrease deaths from cardiovascular disease we need to
understand the mechanisms surrounding xenobiotic pulmonary exposures.
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Chapter 1:
Literature Review

1

1.1 Xenobiotic Particulates
Every day humans are exposed to xenobiotic compounds either intentionally or
unintentional as xenobiotic is broadly defined as anything not naturally produced by or expected
to be present within that organism. Most of these materials are food and drugs that we
knowingly and willingly expose ourselves to, but with each breath we breathe in millions of
particles unintentionally. This group of environmental xenobiotic particles includes air pollution
particulate matter (PM) and other well-established environmental toxicants. Yet, as
nanotechnology continues to flourish the group has expanded to encompass not only PM but
also anthropogenic particles, such as engineered nanomaterials (ENM) (163). While these
exposures are nearly ubiquitous the human health impacts may vary between the particles and
require further investigation.

1.1a. Particulate Matter
Ambient air pollution is a mixture of solid and gases in the air produced by vehicle and
industrial emissions and dust, pollen and other small molecules that can be suspended within
the air. In general, the non-soluble solid fraction of air pollution is termed particulate matter
which is a non-specific term in itself. PM is a complex mixture of components of varying
chemical composition and size. PM can be separated by its aerodynamic diameter into four size
ranges: PM10, <10 µm; coarse particles, 10 µm to 2.5 µm; PM2.5, <2.5 µm; and Ultra-Fine
Particles (UFP), <100 nm. The size of the particle within the PM is directly linked to the adverse
health outcomes associated with exposure (18). Once inhaled, particle size dictates pulmonary
deposition and retention directing particle toxicity.
Throughout the United States the Environmental Protection Agency (EPA) regulates the
concentration of two different PM sizes: PM10 and PM2.5. Historically, the EPA began to regulate
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total PM concentration in the 1970s without size distinctions. This ruling continued until 1997
when the EPA detailed that particle size dictates toxicological response as indicated by
increased toxicity associated with PM2.5 exposure as compared to PM10 (9). Thus regulations on
both PM10 and PM2.5 were set: with PM2.5 set lower to attempt to alleviate negative health
impacts.
The World Health Organization estimates that ambient air pollution contributes to 3.7
million premature deaths a year (184). Epidemiologically, exposure to PM contributes to acute
cardiovascular morbidity and mortality (17). Further, PM2.5 exposure increases the risk for
cardiovascular events such as myocardial infarction, stroke, arrhythmia and exacerbation of
heart failure within hours of exposure (137, 156). While long-term exposure can reduce life
expectancy by a few years, short-term increases in PM2.5 exposure can lead to increased early
mortality in thousands of individuals within the United States (US) (17, 137). Although PM
exposure is widespread, the makeup of this material varies considerably based on origin and
geographical region (47). This further suggests that particle composition differentially
contributes to the adverse health impacts following exposure (38).

1.1a.i. Mountaintop Removal Mining
One regionally-specific PM that is known to impact cardiovascular health is produced as
a by-product of coal mining throughout the Appalachian region of the US. Coal mining can be
accomplished through two main methods: underground and surface mining. Underground
mining is the more conventional type of mining where the miners dig into the soil and rock
through shafts and tunnels to remove the mineral deposit. In contrast, during surface mining
miners remove the overburden, soil and rock, from on top of the deposit so they can then
remove the coal. Surface mining relies on the use of heavy machinery; thus, is less labor
3

intensive than underground mining. A decreased labor force is attractive to mining companies
and has led to an approximately 30% increase in surface mining throughout the US (45).
Surface mining is a broad category of mining and includes strip, open-pit and mountaintop
removal mining (MTM).
Mountaintop removal mining is common throughout the Appalachian region: primarily
Kentucky, Virginia, Tennessee and West Virginia. In West Virginia alone, MTM accounts for
approximately 30% of the mining operations throughout the state (45). During MTM, explosives
are utilized to remove the mountain summit to expose the underlying coal seam. Then using
diesel-fueled machinery, the remaining overburden is dumped into the adjacent valleys leveling
the mountain. While the economic and ecological impacts of this mining technique are well
realized; the human health impacts are not fully realized.
Broadly, the health effects of coal mining have been outlined (186, 198), but the
differential impacts of mining type had not been defined. Governmental regulations require
fugitive dust abatement to protect the individuals working and living in areas surrounding active
MTM sites. Yet epidemiologically in the areas surrounding active MTM sites there is an increase
in chronic cardiovascular disease mortality rates (49). Interestingly, this study compared
individuals surrounding active MTM sites and underground mining sites and was able to suggest
that the increased mortality rates could be attributed to the PM in the air. Comparing the PM
concentrations in these areas surrounding different surface mining sites confirmed that PM10
and PM2.5 PM concentration was increased (94) and have a high crustal affinity and primarily
aluminosilicate composition (93). Investigation in to the mechanisms contributing to the
increased cardiovascular mortality rate observed is limited. Animals exposed to the PM
collected in areas surrounding MTM sites (PMMTM) have decreased microvascular function (89)
but the cardiac impacts have not been identified.
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1.1b. Engineered Nanomaterials
The incorporation of nanotechnology into consumer-based products helps to propel this
area into a billion dollar market and at the heart of the market are engineered nanomaterials
(ENMs). ENMs are anthropogenic materials with at least one dimension smaller than 100
nanometers. Naturally humans are exposed to materials within this size range, yet these
particles are commonly classified as ultrafine particles. The difference between these particles
is the intention: ENMs are created intentionally while ultrafine particles are unintentional. As
technology has progressed and we began to manipulate matter at the nanoscale; soon it was
realized nano-sized particles behave differently than their micro-sized counterparts.
Moving from the micron- to nano-sized particles many physicochemical properties can
change. Most notably there is an increase in surface area and mass to charge ratios with the
significant change in size in nanomaterials. Figure 1.1A illustrates how the change in particle
size can affect mass and surface area. One carbon microparticle with a diameter of 60 µm has a
mass of 0.3 µg and a surface area of 0.01 mm2, yet the same mass of carbon in nanoparticulate
form, with each particle having a diameter of 60 nm, has a surface area of 11.3 mm 2 and
consists of 1 billion nanoparticles (20). These changes in physicochemical properties are
essential to their incorporation into consumer products as they can be used in ways different
than their micron sized counterpart. Yet this change in properties can also make them
unpredictable when interacting with biological materials. In Figure 1.1B, a size comparison of a
macrophage and the organelles within the cell compared to particulates of different sizes helps
to illustrate how nanomaterial size may create novel interactions in biology.
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Figure 1.1 Nanomaterial Size Comparisons and Health Consequences. (A) Schematics
illustrating a microparticle of 60 µm diameter, and the number of nanoparticles with diameter
of 600 nm and 60 nm having the same mass as one microparticle of 60 µm diameter. (B)
Comparison of rat macrophage cells size to nanoparticles size using TEM images (at scale).
Human macrophages are up to two times larger than rat macrophages. TEM image (C)
Illustration of human body with pathways of exposure to nanoparticles, affected organs, and
associated diseases from epidemiological, in vivo and in vitro studies. (20)

Nanomaterials have been shown to influence nearly all systems, yet these effects are
not consistent between particles. The inhalation of nanomaterials alone can have negative
impacts from the brain to the skin and everything in-between (Figure 1.1C). Some
nanomaterials seem to be toxic, some non-toxic and others may have beneficial health effects
(13). The ENM nomenclature is a broad category and is made up of particles of varying size and
shape. While to technically be a nanomaterial one dimension must be less than 100 nm, the
other dimensions are not defined and can be micrometers in length. Considering individual
nanomaterials, we are modeling only a few atoms and even though different ENM may be
formed from the same material; the configuration of its atoms can be different resulting in
different physical and toxicological outcomes.

6

1.1b.i. Carbon-Based Nanomaterials
The global market for carbon nanomaterials was $158.6 million in 2014 and is projected
to reach $670.6 million in 2019 (126). Due to their varied size and shape, carbon-based
nanomaterials have a wide range of end-consumer products and is the most quickly growing
class of nanomaterials with a compound growth rate of 33.4% (126). Carbon-based
nanomaterials are a distinct class formed entirely out of carbon but with a wide variety of size
and shapes: ranging from 2-dimensional graphene sheets to 3-dimensional fullerene spheres
and carbon nanotubes (CNT). These shapes imbue them with unique properties like the high
electrical conductance found in a graphene sheet or tensile strength of a multi-walled carbon
nanotube (MWCNT). While they are widely useful in technology and consumer applications
considerable concern has been raised in reference to their human health effects (121). Health
hazards are most obvious with manufacture/workplace exposure, but general exposures from
use, degradation or disposal of commercial products as well as direct exposure through
biomedical applications are a growing concern (39, 168).
CNT are especially interesting due to their physicochemical properties: 10-fold stronger
than steel, 1.2-fold harder than diamond, light and heat resistant and exhibit unique electrical
properties (44). These unique physicochemical properties lend to increased durability, which
from an engineering perspective is attractive, but this durability remains in exposure scenarios
and increases biopersistence in the lung (95). In fact, some studies suggest MWCNT may be
analogous to asbestos in the induction of mesothelioma (136). Yet, cardiac impacts are not
defined following pulmonary exposure to CNT.
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1.1b.ii. Titanium Dioxide
While the use of carbon-based nanomaterials is rapidly growing, titanium dioxide (TiO2)
use is one of the most commonly used materials and is one of the top 5 nanoparticles produced
annually (149). TiO2 is a white pigment commonly used in paints, coatings, plastics, paper, inks,
medicines, food products and personal care products to enhance the color and brightness of the
product; it is also found in sunscreen to provide protection from the sun’s ultraviolet rays.
Traditionally, micron-TiO2 has been considered a poorly soluble and low toxicity particle (81). To
this end, micron-TiO2 was used as a “negative control” in many in vitro and in vivo toxicological
studies (195). While TiO2 is a relatively inert nanomaterial, compared to its micron-sized
counterpart, nano-TiO2 was as much as 41-fold more potent in causing lung inflammation, lung
damage, inflammatory cytokine/chemokine production and oxidant generation (146). While
inhalation of ENMs may primarily occur through occupational production and degradation, new
consumer products that utilize ENMs can contribute to consumer exposure and fugitive
materials may seep into the environment expanding the exposure risk beyond apparent contact.

1.2 Health Impacts of Xenobiotic Exposures
As stated previously, humans are constantly subjected to xenobiotic particles and in
numerous exposure models. Yet inhalation and pulmonary exposures are the most common
route of exposure. In human models inhalation of PM has proven to have negative health
impacts and more specifically negative cardiovascular effects (17, 18). ENM production has
become more prevalent within the last ten years, preventing long-term health effects and
retrospective studies to be well established. Thus while human results indicative of nanomaterial
toxicity are not documented, significant injury and the contributing mechanisms are well
characterized in animal models of exposure.
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1.2a. Pulmonary Consequences
Thorough evaluation of pulmonary impacts following xenobiotic exposure have identified
effects specific to the exposure particulate. Decreased pulmonary function in healthy models is
not commonly identified following particulate exposure, but because the lung is the primary site
of exposure, molecular mechanisms are affected. Between micro- and nanoparticles pulmonary
deposition varies greatly. In simulations of human pulmonary deposition nanoparticle deposition
was more uniform and more likely in the deeper, gaseous-exchange regions of the lung (194).
Observations in animal models support the simulations identifying increased pulmonary
deposition of nanoparticles as compared to micro-particles (52). Thus size not only dictates
response but can also impact pulmonary deposition. In an adult human, this model suggests
that particles 10 microns in size will have a high total deposition, but the bulk of this deposition
will be within the extrathoracic portion of the respiratory tract. Yet, smaller nano-sized particles
have decreased deposition efficiency, but when deposited these materials will deposit into the
gaseous exchange region of the respiratory tract (1). Therefore even though nanomaterials
more specifically deposit in the alveoli, larger particles can still get into this region, but clearance
between these particles varies.
Pulmonary clearance can impact the total deposition but also can be central in the
toxicity identified following exposure. Comparing micron and nano-sized particle macrophage
clearance by observing nanoparticles within bronchoalveolar lavage macrophage populations
more than two-fold higher in the animals exposed to micron-sized particles (58). Following
exposure, the percentage of nanoparticles associated with macrophages increases over time
(90).Further, pulmonary evaluation of the impacts of CNT suggests not only biopersistence but
also an associated inflammatory response following exposure (48, 105). Increased macrophage
recruitment suggest an attempt at removal of the particle but surrounding tissue is damaged
(52).
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TiO2 inhalation exposure shows a dose-dependent deposition of titanium in the
pulmonary tissue and an associated increase inflammatory response as signified by an increase
in neutrophils in the bronchioalveolar lavage fluid (10). Nano-TiO2 pulmonary effects of a
pulmonary exposure are well characterized and extrapulmonary effects are identified with
investigation into how these remote effects manifest (12). Systemic inflammatory spillover from
the lung following nano-TiO2 pulmonary exposure is suggested to be one of the pathways
contributing to the extrapulmonary impacts (80). Specifically, this inflammatory response is great
enough to decrease the in vivo vascular reactivity showing that the cardiovascular system is
affected following nano-TiO2 exposure (119). Yet the mechanisms eliciting extrapulmonary
effects are not well understood and of considerable controversy.

1.2b. Extrapulmonary Influences
While extrapulmonary toxicological effects are well-documented, the mechanisms of
toxicity are still under considerable debate. Three potential hypotheses have been advanced to
explain extrapulmonary effects: [1] a systemic inflammatory response that is initiated in the lung;
[2] translocation of the particles to extrapulmonary tissue; and [3] neural effects (18, 40). Studies
in both murine and human models have identified pro-inflammatory markers in the circulation of
exposed subjects, providing evidence that a pulmonary insult may stimulate a systemic
inflammatory response (7, 69, 131, 139, 145, 170, 179, 181) which may contribute to
downstream cardiovascular effects (115, 120). Data also exists suggesting particulate
translocation from the lung to the affected tissues (46, 91, 123, 124, 164). Pulmonary exposure
damages lung epithelium, increasing permeability and enabling particle penetration from the
gaseous exchange region leading to escape into the circulation with subsequent impact on
extrapulmonary tissues (117, 152). Finally, exposure may interfere with neuronal signaling and
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cardiac autonomic dysfunction following exposure (22, 23, 132). While the hypotheses are
scientifically independent, the mechanisms are not mutually exclusive and may overlap,
propagating activation of additional mechanisms.

1.2c. Cardiovascular Dysfunction
While the pulmonary tissue is the primary site of injury, the link between particulate
exposure and cardiovascular disease is not new.

The cardiovascular system is commonly

identified as one of the affected organ systems following exposure, yet the mechanisms
supporting this association are not fully examined. Sufficient evidence supports that after
exposure to both PM and ENM systemic vascular dysfunction underline cardiovascular
dysfunction (89, 112, 165). In different exposures the mechanisms contributing to this
dysfunction differ as inflammation is culpable in some (120) and particle translocation is
suspected in others (147) suggesting that different particles stimulate distinctive pathological
stimuli. This vascular dysfunction is typically related to peripheral vascular disease and
hypertension but dysfunction of the coronary microcirculation suggests the heart is affected
following exposure and could lead to increased cardiovascular disease mortality (32, 164).
Cardiac function is not a typical endpoint of inhalation toxicology evaluation, but
evidence supports that particulate exposure can interrupt both relaxation and contraction of the
heart. Investigating the effect of diesel exhaust particle inhalation on cardiac function identified
decreases in fractional shortening due to diastolic effects with an increase in end-diastolic
diameter (191). Similarly, decreased fractional shortening following PM exposure was identified
in senescent mice (172). Prenatal PM exposure reduced fractional shortening (61) and a
chronic model of PM exposure decreased ejection fraction (185), demonstrating the detrimental
role PM exposure plays in the progression of heart disease. Cardiac effects are not well
11

documented following CNT exposure but data suggests the tissue is at least sensitized by
exposure (101, 177). In vitro exposure to nano-TiO2 induced impairment of sarcomere
shortening and decreased stability of resting membrane potential (147). In vivo nano-TiO2
pulmonary exposure increases tissue excitability enhancing the propensity for arrhythmias
(147). Also, inhalation exposure to nano-TiO2 can depress diastolic function in animal stimulated
with isoproterenol suggesting decreased capacity for cardiac response following ENM exposure
(85). Following particulate exposure, overt cardiac dysfunction is not commonly observed in
humans; however, cardiac remodeling occurs indicating cardiac stress (180). Ex vivo
assessment of cardiac contractile reserve following PM exposure highlighted deficient cardiac
contractility and correlated this effect with impaired myocardial metabolism suggesting
mitochondrial dysfunction associated with xenobiotic exposure (107).

1.2d. Mitochondrial Dysfunction
The mitochondrion supplies the cell with the energy necessary to maintain homeostasis,
yet following xenobiotic exposure the mitochondrion may become a target. Intentional xenobiotic
targeting to the mitochondria can be used for imaging (50) but unintentional exposure may
stimulate the organelle and propagate toxicity. For example, PM produces changes in
pulmonary mitochondrial morphology and the expression of mitochondrial fission/fusion markers
(100). In vitro, PM induces opening of the mitochondrial permeability transition pore (mPTP),
decreases membrane potential and generates mitochondrial dysfunction in RAW 264.7 cells
(188). Further, silver nanomaterials were also able to induce mPTP opening and decrease
mitochondrial respiration associated with increased reactive oxygen species (ROS) production
(41). Pulmonary exposure to single-walled CNT was accompanied by aortic mitochondrial DNA
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damage and changes in mitochondrial glutathione and protein carbonyls levels suggesting the
cardiovascular mitochondria can be impacted by xenobiotic exposure (101).
Within the heart, mitochondrial swelling following PM exposure was correlated with
cristae disorder and increased oxidative stress (99) then mitochondrial functional deficits (60).
Nano-TiO2 exposure can induce cardiac mitochondrial damage in different exposure models:
after oral administration mitochondrial swelling arose (19) and inhalation induced mitochondrial
dysfunction in both the heart and uterus of pregnant rats (166). Mitochondrial dysfunction
observed following PM exposure was correlated to impaired cardiac oxygen consumption and
decreased contractility (107) indicative of impaired metabolism and could represent an early
cardiovascular alteration induced by xenobiotic exposure.

1.2e. Oxidative Stress
Oxidative stress is defined as the imbalance of ROS generation and antioxidant defense.
Oxygen-derived free radicals such as superoxide and hydroxyl radicals, as well as non-radical
derivatives such as hydrogen peroxide and peroxynitrite, are the key drivers of oxidative stress
that can impair cellular and organelle function. Following xenobiotic exposure an increase in
systemic oxidative stress is well characterized and oxidative potential has been used as an
effective exposure metric in identifying toxicity within diverse xenobiotic particle exposures (87).
In vitro studies demonstrate a clear link between particulates and ROS generation (41, 111,
135), and in vivo studies consistently support increased levels of oxidative stress in xenobiotic
exposure (101, 119). Vascular impairments observed can be attenuated by pretreatment or
coadministration of free radical scavengers and other antioxidant compounds suggesting ROS
is an important mechanism in cardiovascular dysfunction induced by xenobiotic exposure (28,
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116). Further, while there are different intracellular sources of ROS, due to its high respiratory
capacity the mitochondrion is central in ROS production.

1.2f. Apoptotic Signaling
Apoptosis, or programmed cell death, is an evolutionarily conserved process involved in
distinct physiological processes, yet deregulation of the process is central in the etiology of
several diseases. Xenobiotic exposures can induce apoptotic cell death and contribute to the
collection of pathological conditions observed. In vitro PM exposure induces significant oxidative
stress leading to DNA damage triggering apoptosis in alveolar epithelial cells (176). Other
pulmonary cell lines exposed to ENMs corroborate the induction of apoptosis through ROS
mediated pathways and additionally suggest a mitochondrial role in the initiation (183, 189,
190). Extrapulmonary cellular death investigation following exposure is limited but in vitro
analyses suggest ENMs induce apoptosis in the liver but mechanisms initiating death are
absent (150, 155). Finally, in a rat cardiac cell line (H9C2 cells) PM exposure initiated apoptosis
through ROS mediated pathways and mitochondrial associated proteins (21), yet in vivo
analyses of extrapulmonary apoptosis and the contributing mechanisms following xenobiotic
exposure are lacking.

1.3 Pulmonary Exposure Models
The evaluation of airborne xenobiotic materials extrapulmonary impacts begins with
exposing the animal’s lung and there are many ways to accomplish this exposure. Inhalation
exposure is considered the gold standard as this provides a natural route of entry, but there are
many obstacles that can prevent the use of this technique. Inhalation, especially nanomaterial
inhalation, can require special equipment and expertise not available at many institutions or if
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available are too expensive to maintain. Even when inhalation facilities are available, other
factors may make inhalation unfeasible: limited test material, highly reactive/toxic material or
hazards associated with material handling that preclude atmospheric generation (42).
Alternative methods, intratracheal instillation and pharyngeal aspiration, are much
simpler and limit the risks to the investigator. Further, these methods can be utilized to assure
the actual dose delivered to the lungs of the animal as inhalation relies heavily on estimations.
During intratracheal instillation, a ball needle is attached to a tuberculin syringe and inserted
under the glottis into the trachea releasing the particulate solution into the lungs (14). Yet in the
mouse, there can be significant trauma associated with the intratracheal instillation method
alone; decreasing the method’s translational relevance and making conclusion into the
xenobiotic impacts difficult. Pharyngeal aspiration is able to decrease exposure associated
trauma as there is no needle insertion. Exposure using pharyngeal aspiration introduces the
exposure solution to the base of the tongue and the animal brings the solution into its lungs with
normal respiration. When utilized with ENM exposures, pharyngeal aspiration deposits the
material into the deep lung and with an even lung distribution correlated to the administered
dose (141). Between exposure models, pulmonary deposition was found to be similar at 24
hours suggesting comparisons of effects are due to particle differences and not exposure
technique (42, 96, 122). Each method is a well validated model of pulmonary exposure with
advantages and disadvantages, but can be utilized to investigate extrapulmonary effects of
xenobiotic exposure.

1.4 Cardiac Function Using Echocardiography
Echocardiography is one of the most widely utilized diagnostic tests in cardiology; being
routinely used in the diagnosis, management and follow-up of patients with suspected or known
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heart disease. Echocardiography uses standard two-dimensional and Doppler ultrasound to
produce quick, non-invasive, cost-effective, and highly accurate images of the heart that can be
analyzed for cardiac functional analyses. In animal models, echocardiography is commonly
used to assess cardiac function in disease and the therapeutic potential of treatments. In both
humans and animals, systolic and diastolic echocardiographic analyses can involve the use of
conventional, speckle-tracking based and pulsed wave Doppler echocardiography to thoroughly
assess disturbances to cardiac function.

1.4a. Conventional Echocardiography
One of the earliest forms of cardiac ultrasound is Motion or “M”-mode echocardiography
and due to its precedent it’s now a member of the class of ultrasound affectionately termed
conventional echocardiography. M-mode is widely accepted to measure volumetric and
diametric cardiac functional indices across multiple cardiac cycles. This technique is used to
provide a right parasternal short axis view of the left ventricle, and by placing a gate through this
two dimensional image we can evaluate the motion of the ventricular walls across one
dimension. This one dimensional view allows for fine measurements increasing temporal and
spatial acuity because the focus is narrowed from the two dimensional trace. By tracing the
motion of the ventricular walls, end-systolic and diastolic volume and diameter quantification
allows for the calculation of ejection fraction and stroke volume of the left ventricle, which can
then be used to calculate cardiac output. While M-mode is reliable enough to identify overt
cardiac dysfunction, it is being considered obsolete by some clinicians (51) as more sensitive
indicators are available.
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1.4b. Speckle-Tracking Based Echocardiography
During recent years, velocity, displacement, and deformation analyses have emerged as
a valuable system for comprehensive and reliable echocardiographic assessment. In order to
perform these analyses, speckle-tracking based echocardiography utilizes natural acoustic
reflections throughout the left ventricular wall and follows these “speckles” throughout the
cardiac cycle to assess wall motion and deformation (59). These speckles move in along the
direction of the wall, and not along the ultrasound beam, thus the technique is angle
independent (133). Two-dimensional echocardiographic images are used in both the right
parasternal short and long axes to fully delineate the movement of the heart throughout the
cardiac cycle. While the technique itself is relatively straightforward, the differences between
wall velocity, deformation, and the relationship of these indices to conventional cardiac function
can be more difficult.
Speckle-tracking based echocardiography measures wall motion with velocity and
displacement as indices, and deformation in the context of strain and strain rate. Velocity and
displacement are uncomplicated: like the basic physics terms, they quantify the movement of
the speckle and the velocity with which it moves. Yet strain and strain rate are more complex.
The term “strain” in everyday language means “to exert” yet in echocardiography is used to
describe deformation. Cardiac deformation and strain values correlate to the thickening and
thinning in the radial parameter and elongating and shortening of the cardiomyocyte in the
longitudinal and circumferential parameters. During contraction, as the wall shortens it also
thickens; thus, radial thickening (positive strain), circumferential shortening (negative strain) and
longitudinal shortening (negative strain) thoroughly evaluate systolic function (Figure 1.2). By
taking into account the time it takes to reach peak deformation (strain) we can calculate the
strain rate augmenting the deformation analysis.
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Figure 1.2 Speckle Tracking Based Strain Axes. Normal cardiac function involves
myocardial deformation along the longitudinal (white arrow), radial (grey arrow), and
circumferential (black arrow) axes of the ventricular wall. Long (A) and short (B) axes view of
the ventricular wall illustrate the strain analyses.

Strain and strain rate measurements are sensitive indicators of sub-clinical diseases
including diabetes (151), myocardial ischemia (182), and non-ischemic cardiomyopathies (103)
and prediction of patient outcomes with heart failure (68). The use of strain and strain rate
analyses in diastole are less abundant but also show high predictive values for the outcome of
patients with idiopathic dilated cardiomyopathy (82). In patients with heart failure with preserved
ejection fraction increased diastolic wall strain correlated with diastolic stiffness, cardiac
remodeling and a higher rate of cardiovascular events (125). Further, by combining strain
analyses with pulsed wave Doppler flow analyses the predictive capabilities are augmented
(27).
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1.4c. Doppler Flow Echocardiography
Doppler flow echocardiography uses the Doppler principle to estimate blood velocity
through the heart. Blood-flow velocity estimation is accomplished by comparing the frequency
change between the transmitted and reflected sound waves. Doppler flow echocardiography
can come in two approaches: continuous and pulsed wave flow. Continuous wave uses a
constant ultrasound beam to detect the Doppler shift of very high velocities but is not capable of
well localizing where the shift is occurring. Pulsed wave Doppler uses short bursts of ultrasound
alternating with pauses to detect shifts in Doppler flow and estimates not only the blood velocity
but also allows for the localization of the movement. Thus, the technique can be used to
measure flow through the mitral valve in order to assess cardiac diastolic function.
When flow across the mitral valve is assessed with pulsed wave Doppler flow, two
characteristic waves are observed. These distinct waves represent the early passive filling of
the ventricle, known as the E wave, and the active filling with atrial systole, designated the A
wave. Classically, the velocity of the E wave is slightly greater than that of the A wave, and the
relationship of these velocities acts on a spectrum to predict diastolic function. A simple ratio
(E/A ratio) between the wave velocities indicates either normal function (~1.5), pseudonormal
(~1.5), impaired relaxation (<1.0), and restrictive filling (>2.0). Further, from the pulsed wave
Doppler flow imaging we can estimate the deceleration and deceleration time of the mitral valve,
by measuring the peak E velocity to the beginning of the A wave, which correlates to ventricular
stiffness (113).

1.5 Apoptosis
Apoptosis, or programmed cell death, is a highly regulated and organized process
characterized by the systematic activation of mechanisms leading to precise biochemical and
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morphological alterations. Initially, apoptotic mechanisms are indicated by initiator caspase
activation, alterations in cellular redox potential, cell shrinkage, loss of membrane asymmetry,
and chromatin condensation. Progressively, the execution phase of apoptosis is characterized
by the activation of execution caspases and endonucleases, apoptotic body formation and cell
fragmentation (72). While the endpoints are similar, the signaling cascades that regulate the
progression of apoptosis can come through two distinct initiator pathways: the intrinsic and
extrinsic pathways (Figure 1.3).

Figure 1.3. Apoptosis Initiation Pathways. Extrinsic and intrinsic pathways of apoptotic
initiation converge on the activation of caspase-3 (red circle). The extrinsic pathway is
instigated when a Fas ligand (Yellow triangle) interacts with a death receptor (purple rods) it
recruits the death-inducing signal complex (DISC) which activates caspase-8 and
subsequently caspase-3. The mitochondria are central to the intrinsic pathway of apoptotic
initiation through the release of cytochrome C (cyto C) which combines with caspase-9 and
apoptosis protease activating factor 1 (APAF1) to form the apoptosome that subsequently
activates caspase-3. Cyto C can be release by mitochondrial permeabilization by either the
pro-apoptotic Bax (red circle) overcoming its antagonist Bcl-2 (blue circle) or the opening of the
the mitochondrial permeability transition pore (mPTP). The mPTP quickly permeabilizes the
mitochondria by forming a pore from the mitochondrial matrix to the cytosol with the putative
components: cyclophilin D (cyp D), the activating component; Adenine Nucleotide Translocase
(ANT), the inner mitochondrial membrane component; and Voltage dependent anion channel
(VDAC), the component of the outer mitochondrial membrane.
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1.5a. Intrinsic Apoptotic Signaling
The intrinsic pathway of apoptosis, also known as the mitochondrial pathway, is
activated by a variety of stimuli, such as environmental stressors. The pathway refers to the
mitochondria due to its role in the apoptotic progression associated with the release of
proapoptotic proteins from the organelle. Mitochondrial components and released proteins such
as cytochrome C (cyto C), apoptosis-inducing factor, the adenine–nucleotide translocator
(ANT), cyclophilin D (cypD), p53, and Smac/Diablo contribute to mitochondrial apoptotic
propagation. The release of cyto C into the cytosol commonly correlates to the induction of
apoptosis through the mitochondrial pathway. Once in the cytosol, cyto C forms a complex with
apoptotic protease activating factor 1 (APAF1) and caspase-9 to stimulate the autocatalysis of
caspase-9 and activation of the complex, the apoptosome (Figure 1.3) (143). Once the
apoptosome is activated this stimulates the activation of execution caspases, such as caspase3, that will then carry out the structural and genetic disruptions observed during apoptosis. Thus
the apoptotic process is propagated by mitochondrial permeabilization and the release of cyto C
which can occur through multiple mechanisms.
Mitochondrial permeabilization can be accomplished through two main processes: the
opening of the mPTP and dysregulated members of the Bcl-2 family of proteins. While the
members of the mPTP are not definitive; putative members of the pore consist of voltagedependent anion-channel (VDAC), ANT, and CypD. CypD is believed to be the activator
component of the pore (4): when it interacts with ANT it recruits VDAC creating a pore from the
mitochondrial matrix to the cytosol through which cyto C can be released (Figure 1.3). The Bcl-2
family of proteins is made up of both pro and antiapoptotic proteins that counteract each other to
control apoptotic initiation. Antiapoptotic Bcl-2 proteins (Bcl-2 and Bcl-xl) regulate the
proapoptotic proteins Bad, Bid, Bim, NOXA, and PUMA (members of the Bcl-2 family of
proteins) to prevent apoptosis. Bax forms a homodimer and moves to the outer mitochondrial
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membrane to create a pore through which cyto C can escape (64). Yet, Bax can also form a
heterodimer with Bcl-2 which prevents the formation of the pore and permeabilization of the
mitochondria (Figure 1.3).

1.5b. Extrinsic Apoptotic Signaling
Induction of apoptosis via the extrinsic pathway is triggered by the activation of death
receptors such as those activated by Fas ligand or FasL (Fas (CD95/Apo-1); by the TNF-related
apoptosis-inducing ligand or TRAIL (DR4, DR5); and by tumor necrosis factor receptor
(TNFR1). Death receptor activation leads to the formation of the death-inducing signaling
complex (DISC) formed by the recruitment of the Fas-associated death domain (FADD),
caspase 8 and the cellular FLICE-inhibitory protein (FLIP). The initiator caspase, caspase-8, is
then processed and activated which further amplifies the apoptotic cascade by activation of
execution caspases, such as caspase-3 (Figure 1.3). Upon death receptor activation, cells have
lower levels of DISC formation and active caspase-8, the progression of the cell death program
relies on an amplification loop created by the cleavage of Bid, a Bcl-2-family protein, by caspase
8 and the resultant release of cytochrome c from mitochondria (88). Suggesting there is a role
for the mitochondria even in the extrinsic pathway of apoptosis initiation.

1.6 Mitochondrial Subpopulations
Localization within the cell is critical to function. We know that proteins and organelles
are positioned near their site of use. Sufficient evidence suggests that the mitochondria,
especially of neural and muscle cells, are functionally heterogeneous within different cellular
locations. Dendritic, somatic, axonal, and presynaptic neural segments require different energy
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and calcium dynamics which are associated with structural and biochemical differences in the
neural regions (86). Within the cardiomyocyte, there are also spatially and biochemically distinct
subpopulations of mitochondria: the subsarcolemmal mitochondria (SSM) which reside below
the sarcolemma and the interfibrillar mitochondria (IFM) that sit between the myofibril contractile
apparatus (Figure 1.4). This feature has been substantiated in numerous mammalian species
including mouse, rat, muskrat, guinea pig, hamster, rabbit, dog, pig, monkey, cow and human
(36, 54, 73, 98, 110, 153, 159, 175). Furthermore, another specific population of mitochondria
populating the perinuclear region within the cardiomyocyte exist and are commonly isolated with
the IFM. Ultimately, the heterogeneity of these subpopulations leads to a differential
mitochondrial response under physiological and pathological stimuli (66, 83, 86, 92, 109, 171).

Figure 1.4. Mitochondrial Subpopulations. A graphic representation (A) and electron
micrograph image (B) of the mitochondrial subpopulations found within myocytes. The
subsarcolemmal mitochondria (SSM), which sit below the sarcolemma, and the interfibrillar
mitochondria (IFM), residing between the myofibrils (75).

1.6a. Functional Differences
Not only are the mitochondrial subpopulations within the cardiomyocyte spatially distinct,
but they are also biochemically distinct with numerous studies reporting distinct functional role
for the SSM and IFM. It is hypothesized that the SSM primarily provide the ATP needed for
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active transport of electrolytes and metabolites through the sarcolemma, in contrast the IFM
supply the myofibrils with the necessary ATP for cardiac contraction (114, 129, 144). While
these hypotheses have not been determined experimentally, they are consistent with the
concept that the location of the mitochondrion is related to the process that it fuels with ATP.
Biochemical functional differences have been outlined between the SSM and IFM
supporting distinct metabolic roles for each subpopulation within the cell (129). In the IFM,
higher respiratory rates as well as succinate dehydrogenase and citrate synthase activities
compared to the SSM. Additionally, higher complex I, II and III oxidation rates (128) and
increased ATP synthase (complex V) activities (6) have been reported in the IFM compared to
the SSM. These biochemical differences may also suggest that the mitochondrial
subpopulations will react differentially to pathological stimuli.

1.6b. Communication between Subpopulations
It has been indicated that mitochondrial subpopulations may be able to communicate
across the cell, providing a platform for mitochondrial synchronization (196). The degree of
interaction between these two subpopulations is of debate but one hypothesis indicates that the
innermost SSM and the outermost IFM are connected through mitochondrial filaments enabling
metabolic coupling (157)

1.7 Pathological Influence on Mitochondrial Subpopulations
With the development of mitochondrial isolation techniques, utilizing both mechanical
and enzymatic procedures to sequentially fraction the spatially-distinct mitochondrial
subpopulations (129), efforts to define their differential reactions to pathological stimuli have
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been pursued. Mitochondrial subpopulations are differentially influenced during ischemia,
ischemia/reperfusion, hypoxia, myocardial infraction, preconditioning, postconditioning, heart
failure, exercise, and diabetes mellitus (75). Ischemia alone led to an increase in ROS
production (26) and decreased mitochondrial function (154) in the SSM. Yet, when the ischemic
event is followed by reperfusion of the blood, both the SSM and IFM were impacted (36, 43).
After chronic hypoxia, both SSM and IFM were functionally impacted but the dysfunction of the
SSM was suggested to be compensatory to decrease ROS production (71). During myocardial
infarction the heart loses blood perfusion leading to ischemia and necrosis within that region.
Following models of myocardial infarction both the SSM and IFM respiratory rates were
decreased and ROS production increased (70). Pre- and postconditioning of the heart use
ischemia to protect the heart against a greater ischemic insult. Following preconditioning, the
SSM are primarily protected and this may be a function of initial ischemic condition and calcium
overload (25, 97). Cardiac ischemic postconditioning decreased cardiac injury and helped to
maintain the inner mitochondrial membrane potential reducing the oxidative stress of both
mitochondrial subpopulations (127).
When the heart is unable to sufficiently supply oxygenated blood to the systemic
circulation and enters heart failure the mitochondrion is implicated due to the metabolic
imbalance. Heart failure is induced through either pressure or volume overload and the
mitochondrial subpopulations are differentially impacted based on the stimulus. Pressure
overload induces dysfunction in the IFM (77) while the SSM are primarily impacted by volume
overload induced heart failure (108). Exercise training is associated with mitochondrial
biogenesis (76) and increased mitochondrial enzyme proteins and activities (162). Exercise
training has shown to be effective in decreasing ROS production in both subpopulations of
mitochondria, yet the SSM have increased ROS damage due to decreased antioxidant capacity
(84).
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Finally, mitochondrial dysfunction has been shown to be central in the pathogenesis of
diabetic cardiomyopathy. Diabetes mellitus, which is characterized by lack of insulin (type 1
diabetes mellitus) or insulin resistance (type 2 diabetes mellitus), has shown differential
subpopulation effects. In type 1 diabetes the IFM are most impacted exhibiting decreased
respiratory capacity (35), morphology (173) and dysregulated proteome (5). In contrast, the
SSM from animals with type 2 diabetes have decreased respiratory rates, complex activities and
increased ROS damage (34). This data was echoed in the atrial tissue of diabetic patients
suggesting that mitochondrial subpopulations are differentially impacted by pathology in humans
(33). Ultimately, these studies help to illustrate that mitochondrial subpopulations can be
differentially impacted by pathological stimuli, and that similar stimuli may differentially affect
these mitochondria.

1.8 Mitochondrial Dysfunction
Mitochondria are essential organelles present in all but a few mammalian cell types,
where they perform multiple functions in homeostatic mechanisms. Not only through the
production of ATP from oxidative phosphorylation utilizing the electrochemical gradient
generated across the inner membranes by the electron transport chain (ETC) but also due to its
oxidative and apoptotic potential. Thus, mitochondrial dysfunction is central in the etiology of
many cardiovascular diseases. Further, the mitochondrion may not only be susceptible to
external damage but may be capable of additionally damaging its own membranes, proteins and
DNA exacerbating disease.
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1.8a. Mitochondrial Dysfunction and Oxidative Stress
A number of studies demonstrate that an altered level of oxidative stress in the
cardiovascular environment is crucial to the development of cardiovascular disease. Diatomic
oxygen, despite being a radical species, is the most important oxidant in all aerobic organisms.
Oxygen is sparingly reactive in its basal state, and while O2 can accept two electrons, it rarely
does so at one time. As a result, O2 is usually serially reduced through enzyme-catalyzed oneelectron reductions in vivo and the required enzymes generally contain iron within their active
sites. The ROS term encompasses the superoxide radical, O2˙, hydrogen peroxide, H2O2, and
the hydroxyl radical, OH˙. At physiologic pH, the superoxide radical dismutates or is catalyzed
by superoxide dismutase (SOD) to form H2O2 (53). Cellular sources of ROS include: xanthine
oxidase, NADPH oxidase, arachidonic acid metabolism, microsomal P-450 enzymes, and the
mitochondrial ETC (8).
Within the cell there are multiple sources of ROS generation but the mitochondrion
accounts for about 90% of basal cellular ROS production (30). The respiratory chain is the
major source of ROS production: due to electron leakage from complexes I and III of the ETC
(15, 160). Through the Fenton reaction, superoxide can generate the hydroxyl radical in the
presence of redox metals (i.e. iron, copper). The proteins of the ETC are iron-sulfur centered
proteins, thus they can increase the formation of hydroxyl radicals. Of course the ETC isn’t the
only site of mitochondrial ROS generation: α-ketoglutarate and aconitase generate hydroxyl
radicals from superoxide but this leads to enzyme inactivation (55, 56).
The three main classes of biological materials are susceptible to free radical attack and
suffer oxidative damage in vivo. Oxidation of lipids was the earliest research on the destruction
of biological materials (67). Peroxidative chain reactions occur when a lipid hydroperoxyl radical
extricates a hydrogen from the neighboring unsaturated lipid, forming a hydroperoxide and an

27

alkyl radical which then combines with O2 and regenerates a lipid hydroperoxyl radical
beginning a new round. Ultimately, cyclic endoperoxides and unsaturated aldehydes are formed
inactivating enzymes (169), operating as endogenous fixatives with proteins and nucleic acids
forming heterogeneous cross-links (29), but primarily decreasing membrane fluidity altering
membrane properties and disrupting membrane-bound proteins (24, 174). The oxidation of
proteins is less well characterized, but classes of damage have been identified: oxidation of
sulfhydryl groups, reduction of disulfides, oxidative adduction of amino acid residues close to
metal-binding sites via metal-catalyzed oxidation, reactions with aldehydes, protein-protein
cross-linking, and peptide fragmentation (161, 167). Even though proteins represent a very
diverse target for oxidative damage, there has been little scrutiny of differences between
proteins in their sensitivities. Yet due to proximity, mitochondrial ROS can oxidize the
mitochondrial lipids and proteins found within the inner mitochondrial membrane (IMM), most
importantly the proteins of the ETC.

1.8b. Mitochondrial Dysfunction and Apoptotic Signaling
The mitochondrion plays a major role in the apoptotic signaling in the intrinsic pathway of
apoptosis initiation. One of the key nodal points in mediating cell death and cardiac function is
the opening of the mPTP. While mPTP opening releases pro-apoptotic proteins such as cyto C
and AIF, it also leads to membrane depolarization (78, 193), cessation of ATP production (142),
release of mitochondrial calcium (11), and decreased mitochondrial efficiency leading to
increased ROS generation (197). Demonstratively, mitochondrial dysfunction precedes
apoptosis following in vitro pharmacological induction (63). In animals with a dysfunctional
chaperone protein, α-B-crystallin, mitochondrial dysfunction precedes apoptosis and heart

28

failure (106) further suggesting mitochondrial dysfunction and apoptotic initiation can lead to
cardiac dysfunction.

1.9 Antioxidant Defense Systems
Oxidative stress is the balance between ROS and the antioxidant defense systems of
the cell. The high respiratory capacity of the mitochondrion leads to high ROS production and
have developed an evolutionarily beneficial defense system. The antioxidant defense within the
mitochondria has several mechanisms of defense against enhanced oxidative stress (62). One
mechanism of reducing ROS generation is the uncoupling of the mitochondria by decreasing
mitochondrial membrane potential (158). Yet this results in the decline of oxidative
phosphorylation and ATP production. Thus, the mitochondria more frequently rely on enzymes
to diminish oxidative stress and preserve metabolic function. These enzymatic reactions
include: superoxide dismutation to H2O2 by manganese SOD and H2O2 scavenging by catalase,
peroxiredoxins, or glutathione peroxidases (GPx) (62).

1.9a. Glutathione Peroxidases
Glutathione peroxidases comprise a phylogenetically related family of enzymes whose
main biological role is to diminish the oxidative stress and oxidative damage within the cell.
There are several GPx isozymes with similar functions, but are encoded by different genes and
vary in cellular locations. Mammalian GPx1-4 are selenoproteins with a selenocysteine in the
catalytic center, and GPx6 is a selenoprotein only found in humans. It is well established that
GPxs catalyze the reduction of H2O2 to water, or the corresponding alcohol, using glutathione
(GSH) as a reductant (Figure 1.5) (178). The presence of selenium in the active site is
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Figure 1.5. Glutathione Peroxidase Antioxidant Mechanism. The selenocysteine site of
glutathione peroxidase (A) reduces hydrogen peroxide (H2O2) or lipid peroxides by
glutathione peroxidase 4 (B). Recycling of the glutathione necessary for proper enzyme
function is accomplished by glutathione reductase in both enzymes.
necessary for the antioxidant properties of GPx. At its resting state the selenocysteine site of
these selenoproteins is in a Se (-) form. This site is oxidized by a peroxide to form a selenic acid
group (RSeOH) which is then ensnared by a reduced GSH molecule to form GS-SeR. Another
GSH molecule reduces this to Se (-) again, releasing a GS-SG by-product. The functions of
these enzymes are similar, yet their structures differ. GPx1-3 are homotetrameric proteins, and
catalyze the reduction of hydrogen peroxide and organic hydroperoxides, whereas GPx4 has a
monomeric structure and directly reduces phospholipid and cholesterol hydroperoxides.

1.9b. Glutathione Peroxidase 4
Glutathione peroxidase 4, also referred to as phospholipid hydroperoxide glutathione
peroxidase (PHGPx), is expressed in all cell types and is a unique GPx due to its affinity for lipid
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hydroxides. PHGPx is exceptional as the only antioxidant capable of reducing lipid
hydroperoxides to alcohols and still reducing free H2O2 (104, 178). Similar to other GPxs, the Se
(-) site is oxidized by a hydroperoxide to a selenenic acid group and then reduced with two GSH
molecules, yet this reaction can incorporate a selenadisulfide step. Normally, GS-SG (oxidized
GSH) is recycled by glutathione reductase (GR) at the expense of NADPH/H+ (178). Though, at
low GSH levels, PHGPx converts into a protein thiol peroxidase and creates disulfide bridges in
proteins. If free thiols aren’t available, PHGPx may become cross-linked through
selenenylsulfide bridges or disulfide bridges to other proteins.
Within the cell PHGPx has several isoforms: cytoplasmic, nuclear, and mitochondrial.
Full length PHGPx contains seven exons and differential transcription drives isoform localization
due to divergent targeting sequences. PHGPx RNA is synthesized as a long and short form
owing to two initiation sites within exon Ia of the PHGPx genomic DNA (3, 138). Transfection of
cells with DNA of the short form overexpressed PHGPx in the cytosol but not in the
mitochondria suggesting the short form is cytosolic PHGPx (2). Addition of the long form leader
sequence to the N-terminus of green fluorescent protein results in the localization of the protein
to the mitochondria (2). Thus, the long form is the mitochondrial PHGPx (mPHGPx) with the
signal peptide for mitochondrial transport. In the PHGPx DNA a different first exon in Ib exists
between exon Ia and II containing a nuclear targeting signal (134). This transcript creates the
nuclear isoform of PHGPx, the most unique version of GPx4.
Genetic manipulation of PHGPx in animals has helped to elucidate its importance in
development and role in the response to pathological stimuli. PHGPx knockout mice die at E7.5
in the embryonic stage indicating an essential role for the selenoprotein during development
(79, 192). Lung fibroblasts from heterozygous knockout of GPx4 (GPx4 +/-) were more
susceptible to H2O2, cadmium and cumene hydroperoxide (57). Utilizing PHGPx inactivation in
mice, Seiler et al. identified PHGPx can protect from neurodegeneration through attenuation of
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AIF-mediated apoptosis (148). Corroboratingly, transgenic overexpression provided protection
against oxidative-stress induced apoptosis (65, 140). Numerous in vitro studies agree with these
in vivo reports: PHGPx can protect against oxidants, apoptosis, and DNA damage (16, 31, 102).
While these reports highlight the importance of PHGPx, they do not focus on the
differential importance of GPx4 isoforms in response to various stimuli. In order to direct our
focus on the mitochondrial form’s protective ability, our lab developed a mouse line in which
PHGPx is targeted to the mitochondria at higher expression levels (36). Utilizing this novel
animal

model,

mPHGPx

was

able

to

preserve

cardiac

contractile

following

Ischemia/repercussion (36). Within the mitochondrion, overexpression of mPHGPx was able to
diminish lipid peroxidation and preserved mitochondrial function in both the SSM and IFM
following Ischemia\repercussion. Animals overexpressing mPHGPx were also able to maintain
mitochondrial function and proteomic composition of the IFM during type 1 diabetes mellitus (5).
MPHGPx is specific to the inner membrane space where it interfaces with the IMM and
scavenges phospholipid hydroperoxides to preserve IMM integrity (74, 118). Phospholipids
within the IMM interact with the proteins of the ETC and mitochondrial protein import machinery
essential to the function of the organelle. Therefore, preserving mitochondrial IMM
phospholipids is essential to maintaining mitochondrial function.

1.9c. Antioxidant Defense in Xenobiotic Exposure
Antioxidant defense mechanisms are not commonly investigated but differential
expression of key enzymes involved in attenuating oxidative stress have been identified
following xenobiotic exposure. In humans, circulating SOD and GPx1 levels were increased by
relocating to an area with higher PM concentration (187). In animal models of PM exposure,
decreased expression of SOD, GPx, and catalase are correlated to pulmonary and systemic
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responses to exposure (37, 130). Further, a single exposure to PM can elicit a decrease in
mitochondrial SOD activity in the lung (100). In vitro analysis corroborate these findings,
identifying mitochondrial dysfunction, ROS production and decreased antioxidant capacity
following treatment with ENMs (183). Finally, one recent study suggests that antioxidant pretreatment can protect the heart from particulate-induced ROS-mediated dysfunction (37).

1.10 Summary
Nearly every individual in the industrial world is exposed to xenobiotic particles either in
the form of ambient particulate matter or the emergent class of particles, ENMs. As
nanotechnology has grown into a multi-billion dollar industry, due to their incorporation into
consumer based products, investigation into the toxicological impacts of these materials has not
met the pace of the industrial growth. ROS are heavily implicated in the etiology of adverse
pulmonary and extrapulmonary impacts of exposure. Xenobiotic exposure is also associated
with mitochondrial dysfunction and apoptotic signaling in extrapulmonary tissues. Hence, the
goal of this dissertation was to examine the impacts of xenobiotic exposure on cardiac and
mitochondrial function. Further, a transgenic mouse model overexpressing mPHGPx was
utilized to determine the role of mitochondrial ROS in the initiation of dysfunction.
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ABSTRACT
Throughout the United States, air pollution correlates with adverse health outcomes and
cardiovascular disease incidence is commonly increased following environmental exposure. In
areas surrounding active mountaintop removal mines (MTM) a further increase in
cardiovascular morbidity is observed and may be attributed in part to particulate matter (PM)
released from the mine. The mitochondrion has been shown to be central in the etiology of
many cardiovascular diseases, yet its role in PM related cardiovascular effects are not realized.
In this study we sought to elucidate the cardiac processes that are disrupted following exposure
to mountaintop removal mining particulate matter (PMMTM). To address this question we
exposed male Sprague-Dawley rats to PMMTM, collected within one mile of an active MTM site,
using intratracheal instillation. Twenty-four hours following exposure we evaluated cardiac
function, apoptotic indices and mitochondrial function. PMMTM exposure, elicited a significant
decrease in ejection fraction and fractional shortening compared to controls. Investigation into
the cellular impacts of PMMTM exposure identified a significant increase in mitochondrial-induced
apoptotic signaling as reflected by an increase in TUNEL positive nuclei and increased
caspase-3 and -9 activities. Finally, a significant increase in mitochondrial transition pore
opening leading to decreased mitochondrial function was identified following exposure. In
conclusion, our data suggest that pulmonary exposure to PMMTM increases cardiac
mitochondrial-associated apoptotic signaling and decreases mitochondrial function concomitant
with decreased cardiac function. These results suggest that increased cardiovascular disease
incidence in populations surrounding MTM mines may be associated with increased cardiac cell
apoptotic signaling and decreased mitochondrial function.

Keywords: Mitochondria; Cardiac Function; Particulate Matter; Apoptosis
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NEW AND NOTEWORTHY
We describe for the first time cardiac and mitochondrial dysfunction following an acute
pulmonary exposure to a unique particulate matter which arises from the process of
mountaintop removal, common in surface mining operations. Our findings suggest enhanced
cardiac risk for populations living in close proximity to mountaintop mining operations.
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INTRODUCTION
The World Health Organization estimates that 3.7 million premature deaths a year are
attributed to ambient air pollution (75). While the lungs are the primary tissue impacted by air
pollution exposure, more than 80% of these deaths are due to cardiovascular disease (75).
Throughout the U.S., decreased air quality correlates with adverse health effects including
negative cardiovascular end-points (57, 60, 61, 64). While chronic exposure to air pollution is
the 13th leading cause of worldwide mortality (76), short term particulate matter (PM) exposure
has also been suggested to contribute to tens of thousands of deaths within the U.S. (27, 60).
Air pollution is a complex mixture of many compounds, including PM, and epidemiological data
link PM concentration to adverse cardiovascular effects (84). PM itself is a heterogeneous
mixture of particles that vary in size, chemical composition and origin; nevertheless, persistent
PM formation creates a near universal inhalation exposure. While PM exposure is widespread,
the make-up of this material varies considerably based on origin and geographical region (27).
These differing compositions may play a distinct role in adverse cardiovascular end-points
associated with a specific geographic locale (22).

The U.S. is among the most active coal producing countries in the world (28) and coal
mining is projected to increase over the next 25 years (2). The Appalachian region, which
extends from southern New York to Mississippi and Georgia following the Appalachian
Mountains, contains more than eight hundred active coal mines, accounting for 30% of U.S.
mining activity (25). Due to its inherent less labor intensive methods, surface mining is
beginning to outnumber traditional underground mining two to one (25). One popular, less labor
intensive method of surface mining is mountaintop removal mining (MTM), which utilizes
explosives to remove the mountaintop, freeing underlying coal seams allowing easier extraction.
Economically and ecologically the technique is controversial, but few studies have begun to
investigate the human health impacts in areas surrounding MTM sites. The PM generated by
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the MTM process contains toxicants that are environmentally biopersistent (55) suggesting
potential for negative health effects.

While the goal of industrial processes is to abate dust generation, fugitive dust from
explosive treatment as well as combustion particles from heavy equipment, create a unique PM
(PMMTM). Epidemiologically, health effects of coal mining have been outlined (81, 88) but, until
recently, no comparisons had been drawn between areas surrounding underground and MTM
sites. Studies have reported that PMMTM causes an increase in chronic cardiovascular disease
mortality rates among populations in close proximity to active MTM sites (28). However, the
mechanisms underlying this observation is poorly understood. We have previously reported that
acute pulmonary exposure to PMMTM in rodents is linked to microvascular dysfunction in
extrapulmonary tissue (36). However, studies on cardiac tissue have not been undertaken.

The mitochondrion has been implicated in the etiology of many cardiovascular diseases
due to the crucial roles it plays within the cardiomyocyte. Among the central roles for the
mitochondrion are the production of ATP requisite for cardiac contraction and relaxation as well
as its contribution to the signals initiating cellular apoptosis. In vivo and in vitro analyses have
revealed an increase in apoptosis in numerous tissues following PM exposure (3, 16, 85, 86).
Two pathways reported to activate the apoptotic cascade include the extrinsic pathway via
caspase-8 and the intrinsic pathway involving the mitochondrion. In the intrinsic pathway,
opening of the mitochondrial permeability transition pore (mPTP) allows uncoupling of the
electron transport chain leading to mitochondrial dysfunction and formation of the apoptosome
(31). In vitro evidence suggests that both extrinsic and intrinsic pathways are activated following
PM exposure (20). Nevertheless, it is unclear whether acute PMMTM exposure is associated with
mitochondrial dysfunction or enhanced initiation of the apoptotic cascade.
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The goals of the current study were to determine whether acute PMMTM exposure is
associated with cardiac and mitochondrial dysfunction and to elucidate whether these effects
were associated with mitochondrial-associated apoptosis initiation with an emphasis on the
cardiomyocyte. Our results suggest that acute PMMTM exposure is associated with an increase
in mitochondrial-driven apoptotic signaling, which may contribute to cardiac and mitochondrial
dysfunction. These findings lend insight into the potential mechanisms underlying acute PMMTM
exposure effects in the heart.
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MATERIALS AND METHODS
Experimental Animals
The animal experiments in this study were approved by the West Virginia University
Animal Care and Use Committee and conformed to the most current National Institutes of
Health (NIH) Guidelines for the Care and Use of Laboratory Animals manual. Male SpragueDawley rats were housed in the West Virginia University Health Sciences Center animal facility.
Rats were given access to a rodent diet and water ad libitum.

PMMTM Preparation
PM was collected on 35 mm, 5 µm pore size PTFE fiber-backed filters (Whatman,
Springfield Mill, UK) for 2-4 weeks at two sites within 1 mile of an active MTM site. Particle
storage and extraction from the filters following collection are consistent with previous reports
(24). Briefly, filters were stored at room temperature (20-25ºC) and ambient humidity (10-30%)
prior to extraction. PM extraction was accomplished by gentle agitation in ultrapure water for 96
hours. Then, particle suspension aliquots were dried in a Speedvac (Savant; Midland, MI) and
total particle weight was determined using a microbalance (Metler-Toledo; Columbus, OH).

Intratracheal Instillation
Intratracheal instillation was performed according to the method of Brain et al. (5) as
previously described (36, 45, 46, 49, 50). Briefly, following anesthesia with isoflurane, a ball
needle attached to a 1-ml tuberculin syringe was inserted under the glottis into the trachea, and
300 µl of either vehicle (5% fetal bovine serum in phosphate buffered saline) or vehicle with 300
µg of PMMTM was instilled directly into the trachea. We have previously shown that this dose of
PMMTM partially impaired endothelium dependent microvascular dysfunction (36). The particulate
matter characterization and resuspension was carried out as described previously (36).
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Cardiac Contractile Function
Twenty-four hours following exposure, echocardiography was utilized to assess cardiac
contractile function. For echocardiographic assessment, each rat was anesthetized in a knockdown box with inhalant isoflurane at 2.5% in 100% oxygen. Following anesthesia, ultrasound
images were acquired with a 25 MHz linear array transducer using the Vevo2100 Imaging
System (Visual Sonics, Toronto, Canada). M-mode images were acquired by placing the
transducer to the left of the sternum and obtaining an image at the mid-papillary muscle level. A
gate was placed through the center of the short-axis B-mode image to obtain M-mode
recordings of contractile parameters of the myocardium. Images were acquired using the
highest possible frame rate (233-401 frames/second). Measurements obtained from left
ventricular M-mode images included end-diastolic and end-systolic diameters and volumes,
fractional shortening, ejection fraction, stroke volume and cardiac output. All M-mode image
measurements were calculated over 3 consecutive cardiac cycles and averaged.

Tissue Preparation and Compartment Isolation
After cardiac contractile measurements were performed rats were euthanized and hearts
excised. Atrial and right ventricular tissues were removed and left ventricular tissue was utilized
for the studies. Cytosolic isolation was performed as previously described (77). Subsarcolemmal
mitochondria (SSM) and interfibrillar mitochondria (IFM) subpopulations were isolated as
previously described following the methods of Palmer et al. (54) with minor modifications by our
laboratory (5, 6, 14, 15, 17, 18, 70, 77). Mitochondrial pellets were resuspended in KME buffer
(100 mM KCl, 50 mM MOPS and 0.5 mM EGTA pH 7.4) and utilized for all analyses. Protein
concentrations were determined by the Bradford method using bovine serum albumin as a
standard (8).
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TUNEL Staining
Terminal dUTP nick-end labeling (TUNEL) was performed to detect apoptotic nuclei in
tissue cross sections as previously described (32, 74). Briefly, frozen tissue (10 μm thick) cross
sections of left ventricle were mounted on charged microscope slides (Fisher Scientific;
Pittsburgh, PA), air dried and incubated overnight at 4°C with mouse anti-heavy chain cardiac
myosin antibody (product No. ab50967; Abcam; Cambridge, MA). Sections were then incubated
with goat anti-mouse Cy5-conjugated secondary antibody (product No. ab6563; Abcam), fixed
with 4% paraformaldehyde, and permeabilized with 0.1% Triton X-100 in PBS at 4ºC. Sections
were incubated with the TUNEL reaction mixture (Roche Diagnostics; Indianapolis, IN) in a
humidified chamber in the dark. The exclusion of the TdT enzyme in the TUNEL reaction
mixture on one of the tissue sections on each slide was included as a negative control (Figure
1A). Treatment of one tissue section on each slide with DNase I (Life Technologies; Carlsbad,
CA) was included as a positive control (Figure 1B). Sections were mounted and stained with a
mounting medium containing DAPI (Vectashield; Vector Laboratories; Burlingame, CA) in order
to observe nuclei. Slides were then visualized under a Zeiss Axio Imager Z2 (Carl Zeiss
Microimaging Inc.; Thornwood, NY). The number of TUNEL and DAPI-positive nuclei were
counted and the data were expressed as an apoptotic index, which was calculated as the
percentage of TUNEL-positive nuclei relative to the total myonuclei (i.e., DAPI-positive nuclei)
pool. The apoptotic index was determined from four non-overlapping regions of each tissue
cross section.

Histone Enzyme-Linked Immunosorbent Assay
Cytoplasmic histone-associated DNA fragments related to apoptosis were quantified
utilizing the Cell Death Detection ELISAPLUS kit (product No. 11774425001; Roche Diagnostics).
This photometric enzyme immunoassay which is used for the quantitative determination of
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mono- and oligonucleosomes after cell death, was carried out per the manufacturer’s
instructions.

Western Blotting
SDS polyacrylamide gel electrophoresis (SDS-PAGE) was run on 4-12% gradient gels
as previously described (5, 6, 17, 18, 43, 70, 77). Relative amounts of activated caspase-3, -9
and -8 were determined using specific antibodies: anti-caspase-3 rabbit antibody (product No.
3016-100; Biovision; Milpitas, CA), anti-caspase-9 rabbit antibody (product No. 9665; Cell
Signaling Technology; Danvers, MA) and anti-caspase-8 goat antibody (product No. Sc6134;
Santa Cruz Biotech; Dallas, Texas). Relative amounts of B-cell CLL/lymphoma 2 (Bcl-2), Bcl-2
associated X protein (Bax), apoptosis protease activating factor 1 (APAF-1), and cytochrome c
were determined using specific antibodies: anti-Bcl-2 mouse antibody (product No. sc-7382;
Santa Cruz Biotech), anti-Bax rabbit antibody (product No. ab32503; Abcam), anti-APAF-1
rabbit antibody (product No. ab2000; Abcam) and anti-cytochrome c rabbit antibody (product
No. 4272; Cell Signaling Technology). Relative amounts of mitochondrial permeability transition
pore constituents, adenine nucleotide translocase (ANT), voltage dependent anion channel
(VDAC), and cyclophilin D (CypD) were determined using specific antibodies: anti-ANT goat
antibody (product No. sc-9300; Santa Cruz Biotech), anti-VDAC rabbit antibody (product No.
4866; Cell Signaling Technology) and anti-CypD rabbit antibody (product No. PA1-028; Affinity
Bioreagents; Golden, CO). The secondary antibodies used included: goat anti-mouse IgG
horseradish peroxidase (HRP) conjugate (product No. 31430; Pierce Biotechnology; Rockford,
IL), goat anti-rabbit IgG HRP conjugate (product No. 10004301; Cayman Chemical) and donkey
anti-goat IgG HRP conjugate (product No. sc-2020; Santa Cruz Biotech). Pierce Enhanced
Chemiluminescence Western Blotting substrate (Pierce; Rockford, IL) was used to detect signal
following the manufacturer’s instructions. A G:Box Bioimaging system (Syngene; Frederick, MD)
was used to assess autoradiographic signals. Data were captured using GeneSnap/GeneTools
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software (Syngene) and densitometry was analyzed using Image J Software (National Institutes
of Health, Bethesda, MD). Controls for protein loading included: anti-GAPDH mouse antibody
(product No. ab8245; Abcam) for cytosolic analyses and anti-COXIV rabbit antibody for
mitochondrial analyses (product No. ab16056; Abcam).

Caspase Activation
Caspase activities were assessed as previously described (77, 78). Briefly, whole left
ventricular tissue was homogenized in the absence of a protease inhibitor cocktail to enable
assessment of caspase-3, caspase-8 and caspase-9 activities. All of the activities were
measured in a caspase activation buffer containing 4.8 mmol PIPES, 0.1 mmol EDTA, and 10%
glycerol. For each enzyme activity assay, specific substrates were added: caspase-3, AcDEVD-AFC (Alexis Biochemicals; San Diego, CA); caspase-8, Ac-IETD-AMC (Alexis
Biochemicals); and caspase-9, Ac-LEHD-AFC (Alexis Biochemicals). One hundred µg of each
sample was loaded with the appropriate substrate and allowed to incubate for 2 hours in the
dark at 37ºC. Samples were read fluorometrically using a Flexstation 3 plate reader (Molecular
Devices; Sunnyvale, CA). Fluorometric measurements were performed at excitation/emission
wavelengths of 400 nm/505 nm and expressed in relation to protein content.

Immunoprecipitation
Isolated mitochondrial protein was incubated overnight with a primary anti-Bax rabbit
antibody (product No. ab32503; Abcam; Cambridge, MA). Next, Dynabeads Protein G
superparamagnetic beads (product No. 10003D; ThermoFisher Scientific; Waltham, MA) were
added to the sample mixture and allowed to incubate for 1 hour. After washing the beads, the
protein was eluted, heated, and ran through SDS-PAGE as described above. Following SDSPAGE, immunoblotting for relative amounts of B-cell CLL/lymphoma 2 (Bcl-2) and Bcl-2
associated X protein (Bax) was accomplished as described above.
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Mitochondrial Permeability Transition Pore (mPTP) Opening
mPTP opening was performed as previously described by measuring mitochondrial
swelling, spectrophotometrically (540 nm), and observing the decrease in light scattering (1, 77).
Treatment of freshly isolated

mitochondrial subpopulations with 100 µM tert-butyl

hydroperoxide (t-uBOOH), 400 µM Ca2+ and 10 mM succinate induced swelling and was
followed using a Flexstation 3 plate reader (Molecular Devices; Sunnyvale, CA). As an assay
control, 1 µM cyclosporin A, a specific mPTP inhibitor, was added to the reaction mixture.

Mitochondria Size and Internal Complexity
Size and complexity of the mitochondria were analyzed as previously described (18, 19)
using a FACS Calibur flow cytometer equipped with a 15-MW 488-nm argon laser and 633-nm
red diode laser (Becton and Dickinson; San Jose, CA). Each individual parameter (gating, size
and complexity) was measured using specific detectors and light sources (laser, photomultiplier
tube). The dye MitoTracker Deep Red (product No. M22426, Life Technologies), which
passively diffuses into intact mitochondria, was used to selectively stain for mitochondria.
Freshly isolated mitochondrial subpopulations were incubated with the dye and 20,000 gated
events were analyzed per sample. Gating parameters were established and the forward scatter
detector (FSC; 488 nm argon laser and diode detector) and side scatter detector (SSC;
photomultiplier tube and 90º collection lens) were represented in FSC and SSC density plots. In
order to represent size, FSC (logarithmic scale) geometric mean (arbitrary units) was used; and
to represent complexity, SSC (logarithmic scale) geometric mean (arbitrary units) was observed.
All flow cytometry data collection was supervised by the West Virginia University Flow
Cytometry Core Facility.
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Electron microscopy
A section of left ventricle was cut and fixed in 3% glutaraldehyde in sodium cacodylate
buffer for electron microscopy images. Briefly, sections were post-fixed by incubation with a
1%/0.8% osmium tetroxide/potassium ferricyanide mixture (Electron Microscopy Science,
Hatfield, PA), dehydrated through a graded series of ethanol solutions and acetone then
embedded in Epon resin (SPI Supplies, Westchester, PA). Ultrathin sections (95 nm) were cut
from the resulting blocks with a Leica EM UC7 ultramicrotome (Leica Biosystems, Buffalo
Grove, IL) and then captured on 200 mesh copper electron microscopy grids. The sections were
observed at 80 kV with a JEOL JEM-1010 electron microscope (JEOL USA, Inc., Peabody, MA,
USA) connected to a AMT XR611S-B (ORCA HR) digital camera driven by Image Capture
Engine software (AMT, Woburn, MA) for image acquisition and analysis. All electron microscopy
imaging was performed in conjunction with the West Virginia University Pathology Electron
Microscopy Core Facility.

Mitochondrial Respiration
State 3 and state 4 respiration rates were analyzed in freshly isolated mitochondrial
subpopulations as previously described (12, 13) with modifications by our laboratory (15, 17, 19,
70). Briefly, isolated mitochondrial subpopulations were resuspended in KME buffer and protein
content was determined by the Bradford method (8). Mitochondria protein was added to
respiration buffer (80 mM KCl, 50 mM MOPS, 1 mmol/l EGTA, 5 mmol/l KH2PO4, and 1 mg/ml
BSA) and placed into a Gilson Chamber (Gilson; Middleton, WI) attached to a Yellow Springs
Instruments 5300 biological oxygen monitor (Yellow Springs Instruments, Yellow Springs, OH).
Maximal complex I-mediated respiration was initiated by the addition of glutamate (5 mM) and
malate (5 mM). Data for state 3 (250 mM ADP) and state 4 (ADP-limited) respiration were
expressed as nmol of oxygen consumed/min/mg protein.
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Statistics
Mean and standard error (SE) were calculated for all data sets. A Student’s t-test was
employed to analyze differences between treatment groups using GraphPad Prism 5 software
(GraphPad Software, La Jolla, CA). P < 0.05 was considered significant.
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RESULTS
Cardiovascular Function Following PMMTM Exposure
While overt cardiac dysfunction is not commonly an endpoint of PM exposure, acute PM
exposure has been linked to cardiac stress (60); thus, we began our investigation by evaluating
cardiac function using echocardiography. Twenty-four hours following acute PMMTM exposure, a
significant increase in both end-systolic volume and diameter was observed but no significant
changes in end-diastolic parameters were noted (Table 1). Acute PMMTM exposure led to
decreases in ejection fraction and fractional shortening when compared to control animals
(Table 1).

Apoptotic Signaling Following PMMTM Exposure
Cardiac contractile dysfunction is associated with cell death; therefore, we determined
whether acute PMMTM exposure triggered apoptotic signaling in the heart. Cardiomyocytes from
PMMTM exposed animals (Figure 1D) displayed an increase in TUNEL positive nuclei, which
fluorescently labels DNA nicks, as compared to control animals (Figure 1C), suggestive of an
increase in damage downstream of apoptotic signaling. Summary data for TUNEL positive
nuclei in both control and PMMTM exposed hearts can be seen in Figure 1E. To confirm apoptotic
initiation, we determined cytosolic histone contents following PMMTM exposure and found that
exposure significantly increased histone concentrations (Figure 1F).

Downstream signals of the apoptotic pathway may be differentially activated depending
on the pathway of apoptosis initiated by a given stressor. Among the signaling pathways
responsible for the apoptosis cascade are those driven by the extrinsic mechanism (caspase-8)
as well as those driven by the intrinsic mechanism via the mitochondrion (caspase-9 and
caspase-3)(56). No increase in the activity of caspase-8 was observed suggesting, that the
extracellular pathway of apoptotic induction is not activated following PMMTM exposure (Figure
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2A). In contrast, PMMTM exposure enhanced the activity of both caspase-9 (Figure 2B) and
caspase-3 (Figure 2C). These finding were supported by immunoblotting analysis of relative
active caspase concentrations which suggested an increase in caspase-3 (Figure 2F) and
caspase-9 (Figure 2E) relative to control with no change in caspase-8 (Figure 2D) following
PMMTM exposure. These findings indicate that the mitochondrion may play a role in the induction
of cardiac apoptotic signals following acute PMMTM exposure.

Apoptosome formation requires a number of molecular constituents including APAF-1
and cytochrome c (83). Western blot analyses on the cytosolic fraction of left ventricular tissue
from acute PMMTM exposed animals revealed a significant increase in APAF-1 content as
compared to control exposed animals (Figure 3A). Concurrently, there was an increase in the
cytosolic cytochrome c content following acute PMMTM exposure (Figure 3B) confirming a role of
the mitochondrion in cardiac cell apoptotic signaling. Evaluation of mitochondrial cytochrome c
content following acute PMMTM exposure revealed a significant decrease in the SSM
subpopulation (Figure 3C) without impact on the IFM subpopulation (Figure 3D). Taken
together, these findings suggest an enhanced release of cytochrome c from cardiac SSM
following acute PMMTM exposure which leads to apoptosome formation and mitochondriallydriven apoptotic initiation.

To complement our apoptotic signaling analyses, we examined additional non-specific
cellular markers of apoptosis. BH3 proteins are a class of both pro- and anti-apoptotic proteins
found within the cytosol that are differentially expressed following cellular damage and act to
either prevent or propagate apoptosis. Examination of the anti-apoptotic protein Bcl-2, revealed
a significant decrease following acute PMMTM exposure (Figure 4A). In contrast, no significant
difference in the relative content of its antagonistic pro-apoptotic Bax protein was noted (Figure
4B). The decrease in Bcl-2 led to a significant increase in the Bax to Bcl-2 ratio (Figure 4C)
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suggesting a pro-apoptotic cellular environment. Bcl-2 and Bax are able to counteract the
other’s actions by forming dimers, either hetero or homo, to complete their anti- or pro-apoptotic
activities. Therefore, it is the dimerization of these proteins that suggests mitochondrial
apoptotic signaling. Immunoblotting for Bax following immunoprecipitation with an anti-Bax
antibody indicated that there is an increase in Bax:Bax dimerization following exposure (Figure
4E). When investigating the Bax:Bcl-2 dimerization we observed no significant difference in the
levels of Bcl-2 following pulldown with Bax in the animals exposed to PMMTM (Figure 4D). These
results led us to observe an increase in the pro-apoptotic Bax:Bax homodimerization, as
compared to the anti-apoptotic Bax:Bcl-2 heterodimerization following exposure to PMMTM
(Figure 4F). This data further suggests that cardiac mitochondrial apoptotic signaling is
increased following pulmonary PMMTM exposure.

Mitochondrial Permeability Transition Pore (mPTP) opening propensity
Mitochondrial initiated apoptotic signaling is associated with the opening of the mPTP
(42). We investigated mPTP opening propensity by inducing mitochondrial swelling using an
exogenous oxidant (t-BuOOH). When the mPTP is open, the space that is occupied by the
mitochondrial matrix is increased and the time to Vmax represents the rate of pore opening.
Relative absorbance plots are presented for mPTP opening in SSM (Figure 5A) and IFM (Figure
5C). Each plot includes control, acute PMMTM-exposed and an internal control consisting of
cyclosporin A treatment, which limits mPTP opening. In general, IFM displayed greater times to
Vmax as compared to SSM (Figures 5B and 5D; white bars), which is in agreement with other
reports (1, 77). The time to Vmax was significantly decreased in the SSM subpopulation following
acute PMMTM exposure (Figure 5B). In contrast, mPTP opening propensity was not significantly
altered in IFM following acute PMMTM exposure (Figure 5D). These results suggests that mPTP
opening propensity is enhanced following acute PMMTM exposure only in the SSM subpopulation
and as a result, SSM are more susceptible to oxidant-induced apoptotic stimuli.
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Mitochondrial Permeability Transition Pore (mPTP) opening constituents
Because of the observed enhanced mPTP opening propensity, we determined whether
putative constituents of the pore were affected following acute PMMTM exposure. Specifically, we
assessed the contents of ANT, VDAC and CypD in both mitochondrial subpopulations. Acute
PMMTM exposure induced no change in VDAC (Figure 6A and 6B) or ANT (Figure 6C and D6D)
in either mitochondrial subpopulation. In contrast, an increase in the levels of the regulatory
subunit CypD was noted, in the SSM (Figure 6E) following acute PMMTM exposure with no
significant change in the IFM (Figure 6F). These results indicate an increase in the CypD
content in the SSM following acute PMMTM exposure, which may contribute to the increased
pore opening propensity.

Mitochondrial Subpopulation Morphology
mPTP opening is associated with morphological changes to the mitochondrion (31). To
assess the impact of acute PMMTM exposure on mitochondrial morphology, we utilized flow
cytometry to determine relative size and internal complexity as previously described (15, 17-19,
77). Using this approach, we have reported that SSM tend to be larger and more complex than
IFM (15, 17, 18, 77) and data from the current study are in agreement with these reports
(Figures 7A and 7B; white bars). In both the SSM and IFM, there were significant decreases in
forward scatter (size) (Figure 7A) and side scatter (internal complexity) (Figure 7B) following
acute PMMTM exposure. The results were surprising and indicate that both the SSM and IFM
were smaller and had decreased internal complexity following acute PMMTM exposure,
suggesting that mitochondrial morphology may be affected in both subpopulations. Qualitative
assessment of electron micrographs of left ventricular tissues from control (Figure 7C) and
exposed (Figure 7D) indicated that mitochondria were smaller following exposure further
supporting the data presented in Figure 7A.
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Mitochondrial Respiratory Function
Mitochondrial dysfunction is frequently concomitant with increased apoptotic signaling;
therefore, we determined the respiratory capacity following acute PMMTM exposure through
evaluation of state 4 and state 3 respiration rates. Representative respiratory plots for the SSM
and IFM can be seen in Figures 8A and 8C, respectively. We observed a significant decrease in
state 3 respiration (active) following acute PMMTM exposure in both the SSM (Figure 8B) and
IFM (Figure 8D). No significant changes in the state 4 respiration, or resting respiration rate, in
either subpopulation were noted following acute PMMTM exposure. These findings suggest that
acute PMMTM exposure elicits disruption to respiratory capacity in both mitochondrial
subpopulations.
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DISCUSSION

Acute

and chronic

PM inhalation

exposure

contributes to

and exacerbates

cardiovascular disease and mortality (21, 27). Within the Appalachian region, MTM activity
creates a unique exposure, which, combined with mining longevity, may contribute to increased
mortality from chronic diseases. While epidemiological data are convincing, the underlying
mechanisms responsible for increased morbidity following PMMTM exposure are relatively
unexplored. Utilizing an acute pulmonary exposure model, we investigated the effects of acute
PMMTM exposure on cardiovascular function and metabolic disposition. Our data reveal
decreases in cardiac pump function concomitant with increased mitochondria-driven apoptotic
signaling and decreased mitochondrial respiratory function.

Particle composition varies by region in the U.S. and this variability may underlie health
disparities for a given geographical region. Characterization of the particles utilized in this study
indicated elements and sizes similar to those resulting from the combination of mineralogical
materials as well as engine exhaust emission (36). MTM utilizes blasting, crushing and grinding
of materials, which are commonly accomplished and transported by heavy machinery burning
off-road diesel fuel. Validation of the PM was accomplished in another study highlighting natural
and exhaust emissions, primarily geological, surrounding opencast mines similar to MTM (35).
The dominant size range was ultrafine to 0.2 µm, based on mass measurement, and the
principal particle composition was likely crustal with a bulk of particles appearing anthropogenic
in origin (79). Previous elemental analyses support the notion that the bulk of the particle was
from crustal sources (36). Further confirmation of composition was obtained by comparing PM
from MTM sites and non-MTM sites and observing crustal material enriched within the surface
mining samples by factors greater than 10 (39). These authors concluded that the PM was
similar to coal dust and crustal material with the presence of local combustion sources. The
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authors also suggested that due to the nature of the landscape surrounding the mines (steep
valleys with lower wind speeds and less vertical mixing), there would be less PM transport
creating an increase in the inhaled deposited lung deposition and greater health effects (40).
Whether or not these elements and observations are consistent with our observations remain to
be determined in future experiments.

While extrapulmonary toxicological effects are well-documented, the mechanisms of
toxicity are still under considerable debate. Three potential hypotheses have been advanced to
explain extrapulmonary effects: [1] a systemic inflammatory response that is initiated in the lung;
[2] translocation of the PM to extrapulmonary tissue; and [3] neural effects (9, 23). Studies in
both murine and human models have identified pro-inflammatory markers in the circulation of
exposed subjects, providing evidence that a pulmonary insult may stimulate a systemic
inflammatory response (7, 33, 58, 62, 63, 68, 71, 73) which may contribute to downstream
cardiovascular effects (47, 51). Data also exists suggesting PM translocation from the lung to
the affected tissues (26, 38, 52, 53, 67). Pulmonary exposure damages lung epithelium,
increasing permeability and enabling PM penetration from the gaseous exchange region leading
to escape into the circulation with subsequent impact on extrapulmonary tissues (48, 65).
Finally, PM exposure may interfere with neuronal signaling and cardiac autonomic dysfunction
following exposure (10, 11, 59). While the hypotheses are scientifically independent, the
mechanisms are not mutually exclusive and may overlap, propagating activation of additional
mechanisms. Though these mechanisms have not been explored following PMMTM exposure,
acute exposure to other PM has implicated a systemic inflammatory response (44). While this
question is not experimentally addressed in this manuscript, it is a crucial concept in fully
understanding the interaction between pulmonary damage and extrapulmonary toxicity.

77

Acute PM exposure has been shown to contribute to cardiovascular morbidity and
mortality. To investigate the cardiac contractile response following acute PMMTM exposure, we
utilized echocardiography and observed decreases in ejection fraction and fractional shortening,
which were associated with increases in both end-systolic volume and diameter. One study
investigating the effect of diesel exhaust particle inhalation exposure on cardiac function,
reported similar decreases in fractional shortening, yet this functional decrease was due to
diastolic effects with an increase in end-diastolic diameter (82). Similarly, decreased fractional
shortening following PM exposure was identified in senescent mice (69). Prenatal PM exposure
reduced fractional shortening (30) and a chronic model of PM exposure decreased ejection
fraction (80), demonstrating the detrimental role PM exposure plays in the progression of heart
disease. Following PM exposure, overt cardiac dysfunction is not commonly observed in
humans; however, cardiac remodeling occurs indicating cardiac stress (72). Our results suggest
conditions of early cardiac stress and alteration which, if maintained, may contribute to the onset
and progression of cardiovascular disease.

To identify the cellular mechanisms contributing to cardiac contractile dysfunction
following PM exposure, we focused on apoptotic signaling, the role of which has not been
widely investigated in PM toxicology. Research into histological changes following oil
combustion-derived, fugitive emission PM exposure indicated no change in cardiac cell
apoptosis in a chronic model (37). It is unclear why these results differ from those in the current
study, but it may be a function of differences in particle composition or a transient increased
response which ultimately triggers compensatory mechanisms to attenuate cell death. In
addition, the activation of caspase cascades is a critical step in the induction of apoptosis and
our study identified increased cardiac caspase activity following PMMTM exposure. Activation of
both caspase-8 and -9 in the lung following PM exposure has been reported (29). In the current
study, activation of caspase-3 and -9 suggested a mitochondrial role in apoptotic signaling
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associated with PMMTM exposure. Additional studies are needed to determine whether these
effects are specific to the cardiomyocyte. Interestingly, differences in absolute changes following
PMMTM exposure were observed between the TUNEL staining and the caspase activity analyses,
in which TUNEL staining revealed a greater overall change compared to caspase activation. It
should be pointed out that the TUNEL measurements were performed by staining specifically for
cardiomyocytes, while the caspase activities were conducted on whole heart tissue, which may
have diluted the overall absolute change. Further, TUNEL analyses tend to be more sensitive in
terms of absolute detection resolution.

The mPTP is considered a key nodal point in mediating cardiac dysfunction and cellular
death. Pore opening enables release of pro-apoptotic proteins including cytochrome c. Our
study revealed increased propensity for mPTP opening specifically in the SSM following PMMTM
exposure. While the constituents of the mPTP have been debated, CypD has been regarded as
the regulatory subunit of the pore and necessary for pore opening (4). Our study revealed no
difference in the content of putative pore constituents VDAC and ANT, yet we observed a
significant increase in CypD content in the SSM following PMMTM exposure. These data support
a hypothesis of increased pore opening propensity specific for the SSM following PMMTM
exposure. Differential subpopulation responses to apoptotic stimuli are consistent with other
pathological models (1, 77).

Many studies indicate that mitochondrial spatial location may be associated with a
specific

response

to

pathological

stimuli

(34).

Two

spatially-distinct

mitochondrial

subpopulations have been noted in the myocyte: SSM, which reside below the cell membrane,
and IFM, which exist between the myofibrils. In the current study, SSM displayed increased
apoptotic propensity following PMMTM exposure. In contrast, both mitochondrial subpopulations
displayed decreased active respiration rates after PMMTM exposure. These findings indicate that
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following PMMTM exposure there could potentially be a spatial component to metabolic insult.
Further, these data suggest that SSM are impacted to a greater extent by PMMTM exposure and,
based on their spatial position, we speculate that the primary source of cellular stress comes
from outside the sarcolemma. SSM act as a protective barrier to the cell interior, maintaining
permissive oxygen levels and the resulting cellular milieu (41, 66). We theorize that the impact
to SSM supports the hypothesis that a pulmonary particle insult stimulates a systemic response,
such as inflammation, which affects the cell at its periphery. It has been indicated that
mitochondrial subpopulations can communicate across the cell, providing a platform for
mitochondrial synchronization (87). The degree of interaction between these two subpopulations
is of debate but one hypothesis indicates that the innermost SSM and the outermost IFM are
connected through mitochondrial filaments enabling metabolic coupling (66). If such a scenario
were to exist, one could hypothesize that a significant insult at the SSM could stimulate
dysfunction to the IFM.

In this study we chose to use an acute exposure to PMMTM using intratracheal instillation
at a dose that would be similar to an accumulated dose over 1.7 years. This dose was based on
ambient recorded concentrations of 8.3 µg/m3 and a minute ventilation of 200 ml/min with an
estimated deposition fraction of 0.2 and was chosen because previous effects have been
observed (36). Given that our model resembles a young, healthy population, our findings may
be of even greater significance to older populations and populations with pre-existing conditions.
It should be noted that other methods of pulmonary exposure (e.g. inhalation), as well as a
chronic model, may be more translationally relevant. This may be particularly applicable for
heart failure which can be influenced by mitochondrial dysfunction through bioenergetic deficit
and myocyte apoptosis, both of which contribute to contractile dysfunction and cardiomyocyte
loss. Yet because of the limited mass of PMMTM particle collected, more demanding exposure
approaches were not possible. Also due to the limited particle mass, elemental analysis was not
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undertaken thus conclusions between elements and their contribution to the reported
observations were not drawn. Indeed, future studies should employ inhalation exposure and indepth elemental analysis in order to couple effects with a specific toxicant. Nevertheless,
investigations into the acute effects of PMMTM exposure are not without value, as they provide
insight into the potential toxicological mechanisms elicited by PMMTM exposure.

Though the current study is aimed at the populations proximal to MTM sites, our findings
could provide a broader impact on our understanding of cardiovascular toxicology. The data
presented in this manuscript show for the first time that exposure to PMMTM induces cardiac
dysfunction concomitant with increased mitochondrial associated apoptotic signaling and
decreased mitochondrial function. Further, our findings suggest that there is a spatial
component to this dysfunction, as evidenced by differential effects to spatially-distinct
mitochondrial subpopulations.
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Table 2.1
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Table 2.1. M-Mode Echocardiographic Measurements. Values are means ± SE; n = 10 for
each group. *P<0.05 for Control vs. Exposed.
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Figure 2.1
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Figure 2.1. Cardiac Apoptotic Index Following PMMTM Exposure. Representative fluorescent
images of cardiac tissue with exclusion of TdT enzyme (A) Negative control; (B) positive control
with inclusion of DNase I; (C) control with vehicle instillation; and (D) exposed with PMMTM
instillation. DAPI stained nuclei are indicated in blue while TUNEL positive nuclei are shown in
green and red indicates heavy chain cardiac myosin. Scale bar: 50 μm. (E) Apoptotic index was
calculated as the percentage of total cardiomyocyte nuclei that were TUNEL positive nuclei.
Values are mean ± SE; n = 3 for each group. (F) Relative cytosolic histone concentrations
determined by ELISA on left ventricular tissue from control and PMMTM exposed animals. Values
are mean ± SE; n = 5 for each group. *P<0.05 for Control vs. Exposed.
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Figure 2.2
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Figure 2.2. Cardiac Caspase Activities and Content Following PMMTM Exposure.
Fluorometric analysis of enzymatic activities of (A) caspase-8; (B) caspase-9; and (C) caspase3 from the cytosol of rat left ventricles exposed by instillation to either vehicle control or PMMTM.
Data are expressed as arbitrary units (AU). Relative protein contents of activated caspases from
cytosolic fractions from left ventricles of rats exposed by instillation to either vehicle control or
PMMTM. Representative Western blots (top) and densitometric analyses (bottom) for total protein
content of (D) caspase-8; (E) caspase-9; and (F) caspase-3. All Western blots are expressed
per GAPDH levels. Values are means ± SE; n = 6 for each group. *P<0.05 for Control vs.
Exposed.
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Figure 2.3
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Figure 2.3. Apoptosome Constituent Contents. Relative protein contents of apoptosome
constituents from cytosol and isolated mitochondrial subpopulations from left ventricles of rats
exposed by instillation to either vehicle control or PMMTM. Representative Western blots (top)
and densitometric analyses (bottom) for total protein content of (A) cytosolic apoptosis protease
activating factor 1 (APAF1); (B) cytosolic cytochrome c (Cyto C); (C) cytochrome c in the SSM;
and (D) cytochrome c in the IFM. Cytosolic proteins (A and B) were expressed per GAPDH
levels, while mitochondrial analyses (C and D) were expressed per COX IV levels. Values are
means ± SE; n = 8 for each group. *P<0.05 for Control vs. Exposed.
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Figure 2.4
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Figure 2.4. BAX and Bcl-2 Protein Contents. Relative protein contents of total-cell markers of
apoptosis from left ventricles of rats exposed by instillation to either vehicle control or PM MTM.
Representative Immunoblots (top) and densitometric analyses (bottom) for cytosolic (A) Bcl-2associated X protein (BAX) and (B) B-cell lymphoma 2 (Bcl-2). (C) Ratio of densitometric
analysis of Bax to Bcl-2. Western blots are expressed per GAPDH levels. Immunoblots from coimmunoprecipitation with Bax suggesting the formation of hetero- or homo-dimers with (D) Bcl-2
or (E) Bax. Ratio of densitometric analysis of Bax dimers with Bax to Bcl-2 (F). Values are
means ± SE; n = 8 for each group, *P<0.05 for Control vs. Exposed.
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Figure 2.5
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Figure 2.5. mPTP Opening Propensity. Mitochondrial permeability transition pore (mPTP)
opening propensity from left ventricles of rats exposed by instillation to either vehicle control or
PMMTM. Spectrophotometric analysis of mPTP opening propensity using the exogenous oxidant
t-BuOOH to induce mitochondrial swelling. Time to Vmax was assessed over a 15 minute time
period. Representative absorbance plots for (A) SSM and (C) IFM. Solid lines represent control,
dashed lines represent exposed and dotted lines represents the internal control, cyclosporine A
(CsA) treatment. Vmax data graphed for (B) SSM and (D) IFM. Values are means ± SE; n = 6 for
each group. *P<0.05 for Control vs. Exposed.
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Figure 2.6
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Figure 2.6. mPTP Components. Relative protein content assessed by Western blotting of
putative members of the mitochondrial permeability transition pore (mPTP) from left ventricles of
rats exposed by instillation to either vehicle control or PMMTM. Representative Western blots
(top) and densitometric analyses (bottom) for (A) total voltage dependent anion channel (VDAC)
in SSM and (B) in IFM; adenine nucleotide translocase in SSM (C) and IFM (D); cyclophilin D in
SSM (E) and IFM (F). All Western blots are expressed per COX IV levels. Values are means ±
SE; n = 8 for each group. *P<0.05 for Control vs. Exposed.
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Figure 2.7
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Figure 2.7. Mitochondrial Morphological Assessment. Relative size and internal complexity
were analyzed using mitotracker deep red 633 and flow cytometry. (A) Analysis of cardiac SSM
and IFM size (FSC) in control and exposed mitochondria subpopulations. (B) Analysis of
cardiac SSM and IFM internal complexity (SSC) in control and exposed mitochondrial
subpopulations. Representative electron micrographs of left ventricle tissue from control (C) and
PMMTM exposed (D). Values for both FSC and SSC are expressed as arbitrary units (AU) ± SE;
n = 8 for each group. *P<0.05 for Control vs. Exposed.
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Figure 2.8
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Figure 2.8. Mitochondrial Respiratory Capacity. Representative polarographic traces of
oxygen consumption following addition of glutamate and malate to (A) SSM and (C) IFM. Solid
line traces represent mitochondria from control and dashed line traces represent mitochondria
from PMMTM exposed. Summary analyses of state 3 and state 4 respiration rates from trace
measurements of (B) SSM and (D) IFM. Respiration rates are expressed in nmol·min-1·mg
protein-1.Values are means ± SE; n = 6 for each group. *P<0.05 for Control vs. Exposed.
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ABSTRACT
While carbon-based nanomaterial use continues to grow, the health effects of inhalation
exposures are not fully realized. Following nanomaterial pulmonary exposure, extrapulmonary
effects are recognized but cardiac effects are not well defined. Further, the in vivo mechanisms
describing the subcellular impacts of exposure, especially within the cardiomyocyte, are
undetermined. The current study investigated the impact of pulmonary exposure to multi-walled
carbon nanotubes (MWCNT) on cardiac and mitochondrial function. Male C57BL/6 mice were
exposed using pharyngeal aspiration to either 40 µg of MWCNT; 10 µg of MWCNT; or sham,
dispersion media. Four or 24 hours after exposure, conventional and speckle tracking-based
echocardiography

were

utilized

to

assess

cardiac

function.

Cardiac

mitochondrial

subpopulations were then isolated and run through polarographic assessments for
mitochondrial oxygen consumption, and mitochondrial hydrogen peroxide (H2O2) production
was measured using the fluorescent dye Amplex red. Differential strain analyses were identified
between the doses suggesting MWCNT exposure dose dictates response. Yet both doses of
MWCNT decreased active respiration rates in mitochondrial subpopulations at four hr compared
to controls (P<0.05), but only the dysfunction associated with the 10 µg dose persisted at 24 hr
(P<0.05). Increased production of H2O2 was observed 24 h after exposure to 40 µg MWCNT as
compared to shams (P<0.05). Increased myoglobin in the 40 µg MWCNT exposure (P<0.05)
may act as a compensatory mechanism to rectify mitochondrial dysfunction but contribute to
reactive oxygen species production. In conclusion, cardiac disruptions and mitochondrial
dysfunction was observed following acute pulmonary exposure to MWCNT.

Keywords: Mitochondria; Cardiac Function; Nanomaterials; Reactive Oxygen Species; MultiWalled Carbon Nanotubes
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INTRODUCTION
While nanotechnology is continually growing into a billion dollar industry, carbon-based
nanomaterials are already being utilized for a wide variety of applications ranging from industrial
to biomedical. Multi-walled carbon nanotubes (MWCNT) are described as many hollow cylinders
of carbon atoms stacked inside one another. The global market for MWCNT continues to grow
as the number of applications continually increases; and with the increasing market, industrial
production and widespread distribution into consumer products raises considerable concern for
the human health effects of exposure to MWCNT.

The unique physicochemical properties that make MWCNT revolutionary in consumer
products are the same properties that may elicit toxic effects when exposure occurs. To date, no
human end-points following exposure have been realized thus extrapolation from rodent
toxicological studies is relied on to drive regulatory decisions. Yet even within rodent models,
the cardiac impacts following exposure to MWCNT have not been fully realized. Systemic
effects such as immunosuppression, systemic inflammation and changes in extrapulmonary
tissue molecular signaling following exposure manifest (18, 19, 27, 28, 34). Within the
cardiovascular system, reduced vascular responsiveness (38) and increased susceptibility to
ischemia/reperfusion injury following MWCNT exposure have been identified (42). Yet the
effects of MWCNT pulmonary exposure on cardiac function and molecular endpoints within the
heart have not been elucidated.

Investigating possible cardiotoxic effects is best accomplished through in vivo
assessments do to the complexity of the cardiovascular system which integrates global pump
function, neurohormonal status, vascular properties and systemic hemodynamics. In recent
years, echocardiography has emerged as the standard cardiac imaging technique even in small
animal models, yet conventional echocardiographic measures lack the sensitivity to capture
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subtle changes in left ventricular performance. Speckle tracking-based strain analyses are able
to provide integrated and detailed information regarding both regional and global LV function,
with much greater sensitivity and specificity than conventional measures (24). Utilizing these
analyses, speckle-tracking based strain echocardiographic analysis has efficiently detected
subtle changes in cardiac performance and identified early differences in response to cardiac
therapies in the left ventricle both globally and regionally (5, 37).

To date, speckle-tracking based echocardiography has not been used to investigate
cardiac function following an inhalation exposure to ENMs. Further, the subcellular mechanisms
that can contribute to cardiac dysfunction and the subclinical indices that may be impacted have
not been characterized. In single-walled carbon nanotube pulmonary exposure aortic protein
and mitochondrial DNA were damaged by ROS highlighting cardiovascular oxidative milieu
disruption effecting subcellular organelles (25). But the disruptions of subcellular cardiac
mechanisms following a pulmonary exposure to MWCNT have not been well characterized.

The mitochondrion has been implicated in the etiology of many cardiovascular diseases
due to the many crucial roles it plays within the cardiomyocyte. Among the central roles for the
mitochondrion are the production of ATP requisite for cardiac contraction and relaxation as well
as its production of reactive oxygen species that can be used for signaling or produce damage
to cellular materials. In vitro analyses have observed an increase in ROS production from
mitochondrial sources and increased mitochondrial ROS damage following exposure to CNT
(21). Yet, in vivo cardiac mitochondrial analysis of exposure impacts have not been recognized.

To safely integrate nanomaterials into our lives we need to fully realize the health
impacts of these materials. Thus, the goal of the current studies was to examine the impact of
acute pulmonary exposure to MWCNT on the heart and identify mechanisms contributing to
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cardiac functional disturbances. To test this question we will use a well characterized MWCNT
and state-of-the-art echocardiographic techniques coupled with in-depth mitochondrial
functional analyses to characterize the functional impacts of these particles. In this study we
identify subclinical cardiac functional aberrations accompanied by increased mitochondrial ROS
production and damage that may arise from mechanisms arising from decreased mitochondrial
function following acute MWCNT pulmonary exposure.
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MATERIALS AND METHODS
Experimental animals
The animal experiments in this study were approved by the West Virginia University
Animal Care and Use Committee and conformed to the most current National Institutes of
Health (NIH) Guidelines for the Care and Use of Laboratory Animals manual. Male C57BL/6J
mice from Jackson Laboratory (Bar Harbor, ME) were housed in the AAALAC-approved NIOSH
Animal Facility were provided food and tap water ad libitum in ventilated cages in a controlled
humidity and temperature environment with a 12 hr light/dark cycle. Animal care and use
procedures were conducted in accordance with the “PHS Policy on Humane Care and Use of
Laboratory Animals” and the “Guide for the Care and Use of Laboratory Animals” (NIH
publication 86–23, 1996). These procedures were approved by the National Institute for
Occupational Safety and Health Institutional Animal Care and Use Committee.

Pharyngeal Aspiration
Pharyngeal aspiration was performed according to the method of Rao et al. (33) as
previously described (20, 46). Mice were anesthetized with isoflurane in a bell jar, placed on a
slant board, and the tongue was gently held in full extension while a 50-µl suspension of
particles was pipetted onto the base of the tongue. Tongue restraint was maintained until the
complete suspension was respired. Less than a minute after exposure, all mice awoke from
anesthesia without visible sequela. Mice were exposed to either 10 or 40 µg of MWCNT
resuspended in a physiologic dosing media (DM) for the vehicle that consisted of mouse serum
albumin (0.6 mg/ml) and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (10 µg/ml) in PBS, with 5
minutes of both external and pulse internal sonication to ensure dispersion. Controls were
instilled with the same volume of dosing media. Previously these doses have shown correlation
to workplace exposures and partially impairment of endothelium dependent microvascular
dysfunction (2, 17).
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Echocardiography
Echocardiographic assessments were carried out as previously described (36). Briefly,
each mouse was anesthetized with inhalant isoflurane then maintained at 1% isoflurane or
lower in order to sustain a physiologically relevant heart rate range for the duration of the
experiment, effectively minimizing consequences of anesthesia. Brightness and motion mode
imaging was accomplished using a 32-55 MHz linear array transducer using the highest
possible frame rate (233-401 frames/second) on the Vevo2100 Imaging System (Visual Sonics,
Toronto, Canada). All images were acquired by one individual.

Conventional echocardiographic assessment was completed on grayscale M-mode
parasternal short-axis images at the mid-papillary level of the LV. All M-mode image
measurements were calculated over 3 consecutive cardiac cycles and then averaged. Speckletracking based strain assessments were performed by tracing the walls of the endocardium and
epicardium on B-mode video loops and analyzed throughout the 3 cardiac cycles using Visual
Sonics VevoStrain software (Toronto, Canada) employing a speckle-tracking algorithm. The
software then generates time-to-peak analysis for curvilinear data as output for strain and strain
rate. The same trained investigator using the Vevo2100 Imaging analysis software (Visual
Sonics, Toronto, Canada) completed all analyses.

Tissue Preparation and Compartment Isolation
Following cardiac contractile measurements mice were euthanized and hearts excised.
Atrial tissue was removed and left and right ventricular tissue utilized for the studies. Cytosolic
isolation was performed as previously described (44). SSM and IFM subpopulations were
isolated as previously described following the methods of Palmer et al. (31) with minor
modifications by our laboratory (3, 4, 11-14, 40, 44). Mitochondrial pellets were resuspended in
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KME buffer (100 mM KCL, 50 mM MOPS and 0.5 mM EGTA pH 7.4) for all mitochondrial
analyses. Protein concentrations were determined by the Bradford method using bovine serum
albumin as a standard (6).

Western Blotting
SDS polyacrylamide gel electrophoresis (SDS-PAGE) was run on 4-12% gradient gels
as previously described (3, 4, 13, 14, 23, 40, 44). Relative amounts of myoglobin were
determined using a specific antibody: anti-myoglobin rabbit antibody (Product No. ab77232;
Abcam, Cambridge, MA). Anti-GAPDH mouse (Product No. ab8245; Abcam, Cambridge, MA)
was utilized to control for protein loading in cytosolic analyses. The secondary antibody used
include: goat anti-mouse IgG horseradish peroxidase (HRP) conjugate (Product No. 31430;
Pierce Biotechnology) and goat anti-rabbit IgG HRP conjugate (Product No. 10004301; Cayman
Chemical). Pierce Enhanced Chemiluminescence Western Blotting substrate (Pierce, Rockford,
IL) was used to detect signal following the manufacturer’s instructions. A G:Box Bioimaging
System (Syngene, Frederick, MD) was used to assess autoradiographic signals. Data were
captured and analyzed using GeneSnap/GeneTools software (Syngene).

Mitochondrial Respiration
State 3 and state 4 respiration rates were analyzed in freshly isolated mitochondrial
subpopulations as previously described (7, 8) with modifications by our laboratory (12, 13, 15,
40). Briefly, isolated mitochondrial subpopulations were resuspended in KME buffer and protein
content determined by the Bradford method (6). Mitochondria protein was added to respiration
buffer (80 mmol/l KCl, 50 mmol/l MOPS, 1 mmol/l EGTA, 5 mmol/l KH2PO4, and 1 mg/ml BSA)
and placed into a respiration chamber connected to an oxygen probe (OX1LP-1mL Dissolved
Oxygen Package, Qubit System, Kingston, ON, Canada). Maximal complex I-mediated
respiration was initiated by the addition of glutamate (5 mM) and malate (5 mM). Data for state 3
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(250 mM ADP) and state 4 (ADP-limited) respiration were expressed as nmol of oxygen
consumed/min/mg protein.

Mitochondrial Hydrogen Peroxide Production
Cardiac mitochondrial hydrogen peroxide production was analyzed following MWCNT
pulmonary exposure utilizing the fluorescent dye Amplex Red. The Amplex Red reagent reacts
with hydrogen peroxide in a 1:1 stoichiometry to produce the red-fluorescent oxidation product,
resorufin. Experiments were carried out following manufacturer’s instructions with minor
modifications. Briefly, isolated mitochondria were incubated with reaction buffer and amplex red
dye was added before fueling mitochondria with glutamate, malate and ADP. Changes in
fluorescence over time were read on a Molecular Devices Flex Station 3 fluorescent plate
reader (Molecular Devices, Sunnyvale, CA) and normalized per milligram of protein.

Mitochondrial Electron Transport Chain Complex Activities
ETC complex I, III, IV and ATP synthase activities were measured in isolated
mitochondria spectrophotometrically as previously described (12, 41). Briefly, complex I activity
was determined by measuring the oxidation of NADH. Complex III activity was determined by
measuring the reduction of cytochrome c in the presence of reduced decylubiquinone. Complex
IV activity was determined by measuring the oxidation of cytochrome c. ATP synthase activity
was measured as oligomycin-sensitive ATPase activity using an assay coupled with pyruvate
kinase, which converts ADP to ATP and produces pyruvate from phosphoenolpyruvate. ETC
activities were normalized to citrate synthase activity per protein content utilizing a Citrate
Synthase Assay Kit (ScienCell Research Laboratories; Carlsbad, CA) per manufacturer's
instructions. Protein content was determined by the Bradford method as described above.
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Lipid Peroxidation Products
Lipid peroxidation was assessed through the measurement of stable, oxidized end
products of polyunsaturated fatty acids and esters: malondialdehyde (MDA) and 4hydroxyalkenal (4-HAE) as previously described (3, 15). Briefly, one molecule of either MDA or
4-HAE reacts with two molecules of N-methyl-2-phenylindole (Oxford Biomedical Research
Company, Oxford, MI) to yield a stable chromophore whose absorbance was measured on a
Molecular Devices Flex Station 3 spectrophotometric plate reader (Molecular Devices,
Sunnyvale, CA). Protein content was assessed by the Bradford method, as above, and values
were normalized per milligram of protein.

Statistics
Mean and standard error (SE) were calculated for all data sets. A One-Way Analysis of
Variance (ANOVA) was employed with a Bonferroni post-Hoc test to analyze differences
between treatment groups using GraphPad Prism 5 (GraphPad Software, La Jolla, CA). P <
0.05 was considered significant.
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RESULTS
Conventional Echocardiographic Measurements following MWCNT Exposure
Cardiovascular function following carbon nanotube pulmonary exposure has been
identified but focused on the vascular impacts of exposure with little focus on cardiac functional
impacts. When considering cardiac function, especially systolic function, it is important to initially
investigate and examine the potential of overt cardiac dysfunction. Using conventional
echocardiographic measurements we are able to investigate the in vivo function of the heart
following acute MWCNT exposure. Throughout our study across both time points and doses we
observed no significant change in any of the conventional measures of echocardiography as
measured by M-Mode echocardiography (Table 1).

Technological

progression

has

enhanced

our

ability

to

measure

subclinical

discrepancies in cardiac function through the use of speckle-tracking echocardiography. Initially,
we do not see a change in any strain parameter four hours after exposure (Figure 1A-D). We
begin to see dose impacting the cardiac strain analyses 24 hours after exposure and identified
that systolic strain was decreased following a 40 µg exposure with no change in the 10 µg
exposed animals as compared to dispersion media (Figure 1E). Inversely, we identified
increased radial strain rate in the 10 µg exposed animals with no significant difference in the 40
µg exposed animals compared to dispersion media (Figure 1F). Continuing our thorough
analysis, we identified a significant increase in the circumferential strain in the 40 µg exposure
yet no change in the 10 µg exposed animals as compared to dispersion media (Figure 1G).
Finally, we observed an increase in the circumferential strain rate following exposure to 10 µg of
MWCNT yet no significant change following a 40 µg exposure as compared to dispersion media
(Figure 1H). This data illustrates that the strain profiles were differentially impacted by dose
throughout our study suggesting that MWCNT exposure dose impacts cardiac function. Further,
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this dose response may not follow a typical dose response relationship with the dose eliciting
differential responses.

Spatially-Distinct Mitochondrial Respiratory Function
Due to the heavy energy input needed throughout the cardiac contractile cycle we
investigated the mitochondrial respiratory function following exposure to MWCNT. Mitochondrial
analyses within the cardiomyocyte are further complicated by the presence of two biochemically
and spatially distinct mitochondrial subpopulations: the subsarcolemmal mitochondria (SSM)
found beneath the sarcolemma and the interfibrillar mitochondria (IFM) that reside within the
contractile apparatus. In the SSM, we observed a decrease in the maximal respiratory rate
(State 3) of both the 10 µg and 40 µg MWCNT exposed animals at four hours (Figure 2A). Yet
at 24 hours we did not observe a change in mitochondrial state 3 respiratory rate in either group
compared to control (Figure 2B). In the basal mitochondrial respiratory rate (state 4) we
detected no functional change at 4 hours in the SSM (Figure 2E), but at 24 hours we observed a
significant increase in the state 4 respiratory rate of the 40 µg MWCNT exposure only (Figure
2F). Similarly in the IFM we observed a significant decrease in the state 3 respiratory rate at
four hours in both the 10 µg and 40 µg MWCNT exposure (Figure 2C). This respiratory
dysfunction was attenuated within 24 hours of exposure as there is no change in state 3
respiration at 24 hours in the 40 µg dose, but the decreased respiration persisted in the 10 µg
exposure (Figure 2D). Yet within the IFM, state 4 respiratory rates are not significantly changed
at either four hours (Figure 2G) or 24 hours (Figure 2H) post-exposure. This data suggests that
cardiac mitochondrial function is impacted four hours following MWCNT exposure but the
dysfunction is adaptively eliminated by 24 hours following exposure.
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Mitochondrial Electron Transport Chain Activities
Within in the inner membrane of the mitochondrion sits the electron transport chain
which is responsible for building a gradient that will drive ATP synthesis. By fueling each
complex with its specific substrates we can isolate and identify the activity of the individual
complex to distinguish dysfunctional enzymes within the greater enzyme chain. Following
exposure to MWCNT, the activities of complexes I, III and IV were not impacted by MWCNT
exposure (Table 2). Yet, Complex V (ATP Synthase) activity was significantly decreased four
hours following exposure to high dose MWCNT pulmonary exposure (Table 2). At 24 hours
following exposure all ETC complexes were returned to control levels (Table 3). This supports
that mitochondrial respiratory dysfunction is observed following MWCNT exposure.

Mitochondrial Hydrogen Peroxide Production
Reactive oxygen species production is difficult due to their short half-life, yet by utilizing
a fluorescent dye that is irreversibly activated by reactive oxygen species we can measure ROS
production by the mitochondria. Four hours after MWCNT exposure we see no change in
mitochondrial ROS production in either the SSM (Figure 4A) or the IFM (Figure 4B).
Mitochondrial ROS production within the SSM 24 hours after exposure was not altered with
either dose of MWCNT (Figure 4C). Yet, within the IFM we see a significant increase in ROS
production at 24 hours but only following a high dose exposure to MWCNT (Figure 4D). This
data suggests that increased mitochondrial ROS production arises 24 hours after MWCNT but
is dose dependent.

Mitochondrial Lipid Peroxidation
Due to the mitochondrion’s propensity for ROS production, we investigated the ROS
damage by-products malondialdehyde (MDA) and 4-hydroxyalkenal (4-HAE) to address if
increased ROS production leads to increased damage within the mitochondrion. Doing so, we
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identified no change in lipid peroxidation of either the SSM or IFM four hours following either
dose of pulmonary MWCNT exposure (Figure 4A and B). Twenty-four hours following exposure
there was a significant increase in the lipid damage by high dose MWCNT exposure in the IFM
(Figure 4D), but no change in the SSM (Figure 4C). Taken together, this data suggests that
ROS production within the IFM may contribute to increased lipid damage following high dose
MWCNT exposure.

Myoglobin Content
Myoglobin, an oxygen-binding hemeprotein, supports ATP generation to preserve the
function of energy-demanding tissues, such as the heart. Following exposure to MWCNT, after
four hours no changes in cytosolic myoglobin content were detected in either group (Figure 5A).
Yet, 24 hours following exposure a significant increase in cytosolic myoglobin content was
observed in the high dose MWCNT exposed animals with no change detected in the low dose
group (Figure 5B). This data suggests that an increase in myoglobin may attenuate
mitochondrial dysfunction, yet lead to increased mitochondrial ROS production and damage.

128

DISCUSSION
With literature to support negative pulmonary impacts of MWCNT exposure fulfilling the
realization of extrapulmonary effects lags behind the commercial incorporation especially in
terms of cardiac impacts. The current study highlights the impact of MWCNT pulmonary
exposure on cardiac and mitochondrial function. Utilizing a readily available and utilized
MWCNT we help to build a foundational study highlighting subclinical cardiac disturbances
accompanied by mitochondrial respiratory dysfunction and ROS production. Our data reveals
irregular cardiac and mitochondrial dose response following MWCNT emphasizing that dose not
only dictates toxicological threshold but also response.

Cardiovascular function has been suggested to be disrupted by MWCNT but to date no
study has investigated cardiac functional disruption following a pulmonary exposure. In this
study we utilize both conventional and speckle tracking-based echocardiography to thoroughly
investigate changes in systolic function post-exposure. In both human and rodent models
speckle tracking-based echocardiography has shown earlier and more sensitive prediction of
cardiac dysfunction (5, 10, 37). In this study we show that 24 hour post exposure a high dose of
MWCNT stimulates changes in systolic strain while a low dose induces change in strain rate.
Normal left ventricular function involves patterns of myocardial deformation which can be
measured through speckle tracking-based echocardiography as a sensitive marker of cardiac
phenotyping (35). In this study we focused on the peak radial thickening and circumferential
shortening of the myocardial fibers during systole and the rate of that fiber deformation index.
The decreased peak strain values observed at 24 hours post high dose exposure suggest both
decreased thickening and shortening of the fiber therefore decreased systolic function. Yet with
the low dose of MWCNT exposure we observed a significant increase in the strain rate in both
the radial and circumferential axes suggesting that the peak deformation isn’t disrupted but the
rate at which the deformation develops is increased following exposure. This suggests a
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metabolic disruption following low dose exposure to MWCNT. While overt systolic dysfunction
was not observed at either dose of MWCNT exposure through M Mode imaging this data
suggests that continued exposure and persistent strain dysfunction could precede systolic
dysfunction.

The mitochondrion plays a large role in maintaining the homeostatic environment within
the cardiomyocyte through ATP generation necessary for cellular function and the production of
ROS as signal molecules or agents of injury. After identifying disturbed cardiac function we
wanted to investigate the function of mitochondrial subpopulations following exposure to
MWCNT. Interestingly, we observed a decrease in the maximal respiratory rate of both the SSM
and IFM of low and high dose exposed animals at 4 hours post-exposure, yet no change in this
same respiratory rate at 24 hours. This data suggests that a strong initial provocation stimulates
mitochondrial dysfunction with either that stimulus dissipating or a compensatory mechanism
correcting the observed dysfunction by 24 hours post exposure. The theory of a compensatory
mechanism activation may be supported by the increased basal respiratory rate of the SSM
from high dose exposed animals 24 hours after exposure.

When pulmonary function isn’t limited, intracellular diffusion of oxygen to the
mitochondria is limiting to the production of ATP. Evidence suggested that MWCNT exposure is
capable of decreasing pulmonary function therefore oxygen deliver to tissue may be limiting and
the need for intracellular transportation of oxygen is increased following exposure (43). The
function of myoglobin was suggested in 1939 as a molecule for oxygen storage, oxygen
transportation and an intracellular catalyst (26). Myoglobin is capable of storing and transporting
oxygen to the interior of the cell where respiring mitochondria are located (39). Work in muscle
fibers showed that the maintenance of oxygen consumption was dependent on the presence of
myoglobin (9). Pharmacological inhibition of myoglobin showed that myoglobin-oxygen binding
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regulated oxidative phosphorylation (16, 45). The active site of myoglobin contains an iron atom
which allows the protein to transport oxygen, yet also opens the molecule to ROS damage and
production. When the iron within myoglobin is oxidized, the active site can then interact with
protein radicals capable of generating more ROS as well as initiating lipid peroxidation (1).
Taken together, the increased myoglobin content observed 24 hours following high dose
exposure to MWCNT may be a compensatory mechanism that unfortunately rebounds leading
to an increase in ROS production and damage by the mitochondria.

While the increase in myoglobin and the potential ROS production by the protein doesn’t
directly necessitate increased mitochondrial ROS production, it is well understood that
increased ROS production and damage can lead to further ROS production and damage. Thus,
mitochondrial ROS production and damage may stimulate myoglobin ROS production and
damage, or the reciprocal may occur, propagating ROS production and damage. When kidney
mitochondria were incubated with isolated myoglobin an increase in lipid peroxidation endproducts were detected suggesting increased myoglobin may direct increased ROS production
(32).

Previously our lab has identified cardiac mitochondrial dysfunction following pulmonary
particulate exposure. In these studies we identified differential mitochondrial impacts between
exposure to particulates of various sizes and chemical composition. Within these studies, we
identified

decreased

mitochondrial

respiratory

rates

of

both

cardiac

mitochondrial

subpopulations following an exposure to a regional specific particulate matter. These
subpopulations are unique because not only are they spatially distinct but also biochemically.
The subsarcolemmal mitochondria (SSM) sit below the sarcolemma, are larger more variable in
size, and may be more resistant to ROS mediated dysfunction. In contrast, the interfibrillar
mitochondria (IFM) sit within the contractile apparatus, are smaller and more compact and have
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a higher respiratory rate compared to the SSM. The particulate matter previously investigated
was a composite particle collected within the Appalachian region and particle size and chemical
composition was not uniform. This study highlighted mitochondrial dysfunction at 24 hours postexposure, but in the current study we identify mitochondrial dysfunction much earlier with the
dysfunction being resolved within 24 hours of exposure. Taking into account the data discussed
within this manuscript suggests that MWCNT can induce mitochondrial dysfunction earlier.
Thus, MWCNT may have greater potential for toxicity than particulate matter. Further, while they
are less than 100 nm in one dimension they can be micrometers in length suggesting that while
they are nanomaterials they may also elicit responses similar to larger materials. Further
investigation into the intermediates differentially impacted through a pulmonary exposure that
elicit extrapulmonary effects can help to elucidate some of the mechanisms contributing to the
cardiac and mitochondrial outcomes.

While extrapulmonary toxicological effects are well-documented, the mechanisms of
toxicity are still under considerable debate and systemic spillover of intermediates from the lung
is highlighted following exposure. Studies in both murine and human models have identified proinflammatory markers in the circulation of exposed subjects, providing evidence that a
pulmonary impact stimulates a pulmonary response large enough to spillover to the systemic
circulation (22) which may contribute to downstream cardiovascular effects (29, 30). Further, by
treating naïve vasculature to serum collected from MWCNT exposed animals Aragon et al.
identified the impact of circulating factors in mediating extrapulmonary impacts following
exposure (2). Interestingly, this study also identified that the effects of MWCNT-induced serum
were not linearly associated with lung burden suggesting the induction of different biological
responses at different doses. While our study does not experimentally address the mediation of
pulmonary impacts to extrapulmonary effects, it is important to realize these mechanisms to fully
appreciate MWCNT induced toxicity.
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With respect to the exposure, while this dose has been previously utilized in numerous
studies to define potential impacts of MWCNT, at a typical occupational exposure of
approximately 10 ug/m3, seen in U.S facilities, it would require a 5 day/week exposure for 19
years in humans to reach the lung burden in the lowest dose (17). These doses were chosen to
identify potential impacts as no study has identified cardiac and mitochondrial impacts in vivo
following exposure to MWCNT. Moving forward, the confirmation of the observed effects in a
sub-chronic inhalation model would be of value. Yet investigation into the effects of acute
exposure on cardiac tissue is not without merit due to the tissue’s essential function. Acute
inhalation exposure has been shown to expeditiously induce cardiac dysfunction and disrupt
subcellular process such as mitochondrial function. While most of these effects have been
identified in particulate matter exposures, the vast majority of literature suggests that
nanomaterials are more toxic than their larger counterparts, with nanomaterial size, shape and
chemical composition also confounding the extrapolation of extrapulmonary impacts. Thus, the
observed effects add to our limited, current understanding of cardiac mechanisms disrupted by
acute nanomaterial exposure.

The exposure concentration used within this study is relevant to an occupational study
but due to the rise of nanomaterial incorporation into consumer products and the limited
pulmonary removal this dose may become relevant to a larger population. The data presented
in this paper shows for the first time that cardiac function is impacted by acute exposure to
MWCNT concomitant with increased mitochondrial ROS production and damage but preceded
by decreased mitochondrial function. Within the disrupted cellular mechanisms, our study
suggests that there is a spatial component to the dysfunction as shown by differential effects in
mitochondrial subpopulations and we suggest that this could allude to a spatial component to
the toxicological trigger.
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Table 3.1
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Table 3.1. M-Mode Echocardiographic Measurements. Values are means ± SEM; n = 8 for
each group.
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Table 3.2
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Table 3.2. Mitochondrial Electron Transport Chain Assessment Four Hours Following
MWCNT Exposure. Mitochondrial electron transport chain (ETC) complex activities were
examined in SSM and IFM four hours following exposure to Dispersion Media, 10 µg MWCNT
or 40 µg MWCNT. ETC complex I, III, IV and V activities were assessed spectrophotometrically
by measuring the oxidation of NADH (complex I), reduction of cytochrome c (complex III),
oxidation of cytochrome c (complex IV) and an assay coupled with pyruvate kinase (complex V).
Enzymatic activities for complexes I, III and IV are expressed as activity per minute per citrate
synthase activity per milligram of protein and complex V is expressed as nmol of NADH per
minute per citrate synthase activity per milligram of protein. Values are expressed as means ±
SEM; n = 8 per each group. SSM: subsarcolemmal mitochondria, IFM: interfibrillar mitochondria.
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Table 3.3
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Table 3.3. Mitochondrial Electron Transport Chain Assessment 24 Hours Following
MWCNT Exposure. Mitochondrial electron transport chain (ETC) complex activities were
examined in SSM and IFM 24 hours following exposure to dispersion media (DM), 10 µg
MWCNT or 40 µg MWCNT. ETC complex I, III, IV and V activities were assessed
spectrophotometrically by measuring the oxidation of NADH (complex I), reduction of
cytochrome c (complex III), oxidation of cytochrome c (complex IV) and an assay coupled with
pyruvate kinase (complex V). Enzymatic activities for complexes I, III and IV are expressed as
activity per minute per citrate synthase activity per milligram of protein and complex V is
expressed as nmol of NADH per minute per citrate synthase activity per milligram of protein.
Values are expressed as means ± SEM; n = 8 per each group. SSM: subsarcolemmal
mitochondria, IFM: interfibrillar mitochondria.
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Figure 3.1

146

Figure 3.1. Speckle-Tracking Based Strain Analyses.

Systolic circumferential and radial

strain and strain rate were analyzed in DM, 10 µg MWCNT and 40 µg MWCNT exposed mice.
Systolic radial strain (A) and strain rate (B) at four hours following exposure to MWCNT.
Circumferential strain (C) and strain rate (D) at four hours following exposure to MWCNT.
Systolic radial strain (E) and strain rate (F) at 24 hours following exposure to MWCNT.
Circumferential strain (G) and strain rate (H) at 24 hours following exposure to MWCNT. Values
are means ± SEM; n = 8 for each group. *P<0.05 for Control vs. MWCNT Exposed. #<0.05 for
10 µg MWCNT exposed vs. 40 µg MWCNT exposed.
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Figure 3.2

148

Figure 3.2. Mitochondrial Respiratory Capacity. Respiratory analyses of state 3 and state 4
respiratory rates in mitochondrial subpopulations following exposure to DM, 10 µg MWCNT or
40 µg MWCNT. Four hours following exposure, state 3 (A) and state 4 (E) respiratory rates in
SSM. State 3 (B) and State 4 (F) respiratory rates 24 hours following exposure in the SSM. Four
hours following exposure, state 3 (C) and state 4 (G) respiratory rates in IFM. State 3 (D) and
State 4 (H) respiratory rates 24 hours following exposure in the IFM. State 3 and state 4
respiration rates were determined in the presence of the substrates glutamate–malate, and
state 3 respiration was examined upon addition of ADP. Respiration rates are expressed in
nmol·min-1·mg protein-1.Values are means ± SEM; n = 8 for each group. *P<0.05 for Control vs.
Exposed. SSM: subsarcolemmal mitochondria, IFM: interfibrillar mitochondria.
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Figure 3.3
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Figure 3.3. Mitochondrial Reactive Oxygen Species Production. Summary data of hydrogen
peroxide production in the SSM over time four hours (A) and 24 hours (B) following exposure to
either dispersion media (DM), 10 µg MWCNT or 40 µg MWCNT utilizing a fluorescent dye
activated by hydrogen peroxide. Hydrogen peroxide production in the IFM four (C) and 24 (D)
hours following exposure to MWCNT. Summary data of hydrogen peroxide production
expressed as change in fluorescence min-1·mg protein-1. Values are expressed as means ±
SEM. n = 8 per each group. *P < 0.05 for Control vs. Exposed. SSM: subsarcolemmal
mitochondria, IFM: interfibrillar mitochondria.
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Figure 3.4

152

Figure 3.4. Lipid peroxidation by-products. Oxidative damage to lipids was assessed in
SSM from animals exposed to dispersion media, 10 µg MWCNT or 40 µg MWCNT four (A) and
24 (B) hours following exposure. This colorimetric assay measured lipid peroxidation byproducts malondialdehyde (MDA) and 4-hydroxyalkenal (4-HAE) MWCNT exposure impacts at
four (A) and 24 (D) hours in the IFM. Results were compared against a standard curve of known
4-HAE and MDA concentrations. Values are expressed as means ± SE. n = 8 per each group.
*P < 0.05 for Control vs. Exposed. SSM: subsarcolemmal mitochondria, IFM: interfibrillar
mitochondria.
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Figure 3.5
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Figure 3.5. Cytosolic Myoglobin Content. Relative protein content of myoglobin from cytosol
from mice exposed to dispersion media, 10 µg MWCNT or 40 µg MWCNT four (A) and 24 (B)
hours following exposure. Representative Western blots (top) and densitometric analyses
(bottom) for protein content. Cytosolic proteins (A and B) were expressed per GAPDH levels.
Values are means ± SEM; n = 6 for each group. *P<0.05 for Control vs. Exposed.
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ABSTRACT
While nanotechnology offers innovation in products from cosmetics to drug delivery,
leading to increased engineered nanomaterial (ENM) exposure; unfortunately, health impacts of
ENM are not fully realized. Titanium dioxide (TiO2) is one of the most widely produced ENM due
to its variety of uses. Extrapulmonary effects following a pulmonary exposure have been
identified with studies highlighting the cardiovascular effects, yet no study has identified cardiac
effects. The goal of this study was to determine the impact of nano-TiO2 on cardiac function and
attempt to maintain cardiac metabolism by exposure. To address this question, control FVB
mice and mice overexpressing the mitochondrial antioxidant phospholipid hydroperoxide
glutathione peroxidase (mPHGPx) were exposed to a commercially available nano-TiO2 and
evaluated 24 hours following exposure. Utilizing state-of-the-art echocardiographic techniques,
diastolic dysfunction was observed following exposure with an E/A ratio greater than 2 and
increased radial strain during diastole (P<0.05), indicative of restrictive filling of the left ventricle.
To investigate the cellular mechanisms associated with the observed cardiac dysfunction, we
investigated mitochondrial function following exposure to nano-TiO2. We observed a significant
increase in ROS production (P<0.05) and decreased mitochondrial respiratory function
(P<0.05). By utilizing our novel transgenic mPHGPx mouse we were able to attenuate
mitochondrial ROS production and dysfunction, along with cardiac diastolic dysfunction
observed with nano-TiO2 exposure. In summary, nano-TiO2 inhalation exposure is associated
with cardiac diastolic dysfunction and mitochondrial functional alterations, which are rectified by
the overexpression of a mitochondrial antioxidant, suggesting ROS in the development of the
dysfunction.

Keywords: Mitochondria; Cardiac Function; Titanium Dioxide; Nanomaterials; Reactive Oxygen
Species; Antioxidant
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INTRODUCTION
Due to the wide range of end-uses and potential product and application incorporation,
the nanotechnology industry is predicted to reach $64.2 billion by 2019 (26). Yet with the
exponential growth of the industry, thorough toxicological evaluation is not able to progress at
the same pace as industrial growth; thus, neither intentional nor unintentional human health
impacts following nanomaterial exposure are fully realized. Nanotechnology is the control of
matter at the nanoscale, which encompasses sizes ranging from 1-100 nm. Manipulating matter
at this scale can instill new properties and functions into the resulting material that allow for
better, new, and/or unique uses for that material. Yet within the context of exposure, these
materials may interact with membranes or proteins in a novel manner eliciting unexpected
toxicological responses. One classic example of increased toxicity at the nanoscale is titanium
dioxide (TiO2).

TiO2 is one of the most broadly applied ENM, commonly used as a pigment and
photocatalyst added to paint, food and sunscreen to enhance the appearance of the product.
Exposure to TiO2 has been shown to induce negative cardiac effects centered on the
dysregulation of the oxidative milieu (36, 37). Functionally, acute pulmonary nano-TiO2
exposure induced diastolic dysfunction in rats (23), yet the direct role of oxidative stress on the
dysfunction is unknown. Long-term gastric exposure to nano-TiO2 has shown to increase
reactive oxygen species (ROS) concomitant with a decreased antioxidant capacity within the
heart (10). In vitro analyses have implicated mitochondrial ROS production as central to the
pathways of toxicity following nano-TiO2 exposure (19). However, the role of the mitochondrion
in the cardiovascular response to acute TiO2 exposure in vivo is not fully understood.

The mitochondrion has been implicated in the etiology of many cardiovascular diseases
due to the crucial roles it plays within the cardiomyocyte. Among the central roles for cardiac
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mitochondria is the production of ATP requisite for contraction and relaxation as well as its
contribution to cellular oxidative milieu. Within the cell, the mitochondrion is the leading producer
of ROS, and ROS damage can obstruct the function of proteins, lipids and DNA. By proximity,
the macromolecules within the mitochondria are most at-risk for ROS damage; appropriately,
the mitochondria have their own antioxidant enzymes to protect their molecules.

Relative to its highly aerobic nature, the myocardium’s antioxidant defense is modest,
which can leave the organ at risk for ROS mediated functional impairment. To aid in the
protection, ROS within the mitochondria are regulated by mitochondrial antioxidant enzymes
including mitochondrial phospholipid hydroperoxide glutathione peroxidase (mPHGPx; GPx4)
(1, 21). GPx4 primarily exists in two regionally specific forms: the long form with a mitochondrial
targeting sequence that exists in the mitochondria (mPHGPx) and the short form which does not
contain the mitochondrial targeting sequence found outside of the mitochondrion (20). This
mitochondrial antioxidant is particularly interesting because it is a lipophilic enzyme capable of
reducing peroxidized acyl groups in phospholipids (42), fatty acids hydroperoxides (35) and
cholesterol peroxides (41) in biological membranes and is the primary antioxidant defense
against oxidation of mitochondrial biomembranes.

Mitochondrial membrane integrity and function is crucial in the preservation of protein
components and mitochondrial respiratory function. Mitochondrial membranes and electron
transport chain enzymes can be damaged by highly reactive products derived from peroxidized
lipids such as malondialdehyde (MDA) and 4-hydroxyalkenal (HAE) (2, 15). Our previous
studies have shown that genetic overexpression of mPHGPx can protect mitochondrial and
cardiac function in the face of diabetes and ischemia/reperfusion injury (3, 14, 18). In vitro
nanotoxicity studies have suggested that exposure decreases antioxidant content including
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GPx4 (30), but in vivo analyses and the effects of genetic overexpression of GPx4 following
exposure have not been conducted.

Taken together, we sought to identify the impact of ENM inhalation on cardiac function
and further investigate, then mitigate, exposure effects on cardiac metabolism. We
hypothesized that nano-TiO2 exposure induces cardiac dysfunction arising from disturbed
metabolic function. In order to test this hypothesis, we will utilize a novel transgenic animal
overexpressing the mitochondrial form of GPx4 (mPHGPx) as a way to eliminate the influence
of cytosolic peroxide scavenging and highlights the protective role of GPx4 on cardiac metabolic
function following exposure. Our results indicate that mitochondria-specific overexpression of
mPHGPx provides protection to both cardiac contractile and mitochondrial function following
nano-TiO2 inhalation exposure.
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MATERIALS AND METHODS
Experimental Animals
The animal experiments in this study were approved by the West Virginia University
Animal Care and Use Committee and conformed to the most current National Institutes of
Health (NIH) Guidelines for the Care and Use of Laboratory Animals manual. Male FVB mice
were housed in the West Virginia University Health Sciences Center animal facility and given
access to a rodent diet and water ad libitum. To verify genetic overexpression, DNA from 3week-old mice was isolated from tail clips and screened using a real-time PCR (RT-PCR)
approach as previously described (3). Briefly, we probed for GPx4 using a custom-designed
fluorometric probe (Applied Biosystems, Foster City, CA) and RT-PCR on an Applied
Biosystems 7900HT Fast Real-Time PCR system (Applied Biosystems).

Engineered Nanomaterial Inhalation Exposure
Nano-TiO2 P25 powder was obtained from Evonik (Aeroxide TiO2, Parsippany, NJ).
Previously, this powder was identified to be a mixture composed of anatase (80%) and rutile
(20%) TiO2, with a primary particle size of 21 nm and a surface area of 48.08 m 2/g. The nanoTiO2 was prepared with care prior to aerosolization by drying, sieving and storing the powder.

The nanoparticle aerosol generator was developed, designed and tested specifically for
rodent nanoparticle inhalation exposures (US patent application # US13/317,472) as previously
described (44). The test atmospheres were monitored in real time with the ELPI (Dekati,
Tampere, Finland) and adjusted manually throughout the exposure duration to assure a
consistent and known exposure for each animal group (Figure 1B). ELPI showed that the count
median aerodynamic diameter of the particles was 131.6 nm (Figure 1A).
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Once a steady-state aerosol concentration was achieved, exposure duration was
adjusted to achieve an estimated deposition of 11.58 ± 0.27 µg. Total deposition was based on
mouse methodology previously described and normalized to minute ventilation using the
following equation: D = F x V x C x T, where F is the deposition fraction (10%), V is the minute
ventilation based on body weight, C equals the mass concentration (mg/m3) and T equals the
exposure duration (minutes).

Echocardiography
Echocardiographic assessments were carried out as previously described (38). Briefly,
each mouse was anesthetized with inhalant isoflurane then maintained at 1% isoflurane or
lower in order to sustain a physiologically relevant heart rate range for the duration of the
experiment, effectively minimizing consequences of anesthesia. Brightness and motion mode
imaging was accomplished using a 32-55 MHz linear array transducer using the highest
possible frame rate (233-401 frames/second) on the Vevo2100 Imaging System (Visual Sonics,
Toronto, Canada). All images were acquired by one individual.

Conventional echocardiographic assessment was completed on grayscale M-mode
parasternal short-axis images at the mid-papillary level of the LV. All M-mode image
measurements were calculated over 3 consecutive cardiac cycles and then averaged. To
assess diastolic function, LV filling was evaluated using mitral valve Doppler echocardiography
and measured over 3 cardiac cycles.

Speckle-tracking based strain assessments were performed by tracing the walls of the
endocardium and epicardium on B-mode video loops and analyzed throughout the 3 cardiac
cycles using Visual Sonics VevoStrain software (Toronto, Canada) employing a speckle-tracking
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algorithm. The software then generates time-to-peak analysis for curvilinear data as output for
strain and strain rate. The same trained investigator using the Vevo2100 Imaging analysis
software (Visual Sonics, Toronto, Canada) completed all analyses.

Tissue Preparation and Compartment Isolation
After cardiac contractile measurements were performed mice were euthanized, hearts
excised and cardiac mitochondria isolated via differential centrifugation. Subsarcolemmal
mitochondria (SSM) and interfibrillar mitochondria (IFM) subpopulations were isolated as
previously described following the methods of Palmer et al. (32) with minor modifications by our
laboratory (3, 4, 11, 13, 40). Mitochondrial pellets were resuspended in KME buffer (100 mM
KCl, 50 mM MOPS and 0.5 mM EGTA pH 7.4) and utilized for all analyses. Protein
concentrations were determined by the Bradford method using bovine serum albumin as a
standard (6).

Mitochondrial Respiration
State 3 and state 4 respiration rates were analyzed in freshly isolated mitochondrial
subpopulations as previously described (7, 8) with modifications by our laboratory (12-14, 40).
Briefly, isolated mitochondrial subpopulations were resuspended in KME buffer and protein
content was determined by the Bradford method. Mitochondria protein was added to respiration
buffer (80 mM KCl, 50 mM MOPS, 1 mmol/l EGTA, 5 mmol/l KH2PO4, and 1 mg/ml BSA) and
placed into a respiration chamber connected to an oxygen probe (OX1LP-1mL Dissolved
Oxygen Package, Qubit System, Kingston, ON, Canada). Maximal complex I-mediated
respiration was initiated by the addition of glutamate (5 mM) and malate (5 mM). Data for state 3
(250 mM ADP) and state 4 (ADP-limited) respiration were expressed as nmol of oxygen
consumed/min/mg protein.
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ATP Synthase Enzymatic Activity
ATP synthase activities were measured in isolated mitochondria spectrophotometrically
as previously described (11, 40). Protein content was determined by the Bradford method as
described above, and activity values were expressed as nmol of NADH oxidized/min/mg protein.

Mitochondrial Hydrogen Peroxide Production
Cardiac mitochondrial hydrogen peroxide production was analyzed following nano-TiO2
inhalation exposure utilizing the fluorescent dye Amplex Red. The Amplex Red reagent reacts
with hydrogen peroxide in a 1:1 stoichiometry to produce the red-fluorescent oxidation product,
resorufin. Experiments were carried out following manufacturer’s instructions with minor
modifications. Briefly, isolated mitochondria were incubated with reaction buffer and amplex red
dye was added before fueling mitochondria with glutamate, malate and ADP. Changes in
fluorescence over time were read on a Molecular Devices Flex Station 3 fluorescent plate
reader (Molecular Devices, Sunnyvale, CA) and normalized per milligram of protein.

Lipid Peroxidation Products
Lipid peroxidation was assessed through the measurement of stable, oxidized end
products of polyunsaturated fatty acids and esters: malondialdehyde (MDA) and 4hydroxyalkenal (4-HAE) as previously described (3, 14). Briefly, one molecule of either MDA or
4-HAE reacts with two molecules of N-methyl-2-phenylindole (Oxford Biomedical Research
Company, Oxford, MI) to yield a stable chromophore whose absorbance was measured on a
Molecular Devices Flex Station 3 spectrophotometric plate reader (Molecular Devices,
Sunnyvale, CA). Protein content was assessed by the Bradford method, as above, and values
were normalized per milligram of protein.
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Western Blotting
SDS polyacrylamide gel electrophoresis (SDS-PAGE) was run on 4-12% gradient gels
as previously described (3, 4, 13, 24). Relative amounts of Glutathione Peroxidase 1 (GPx1),
Glutathione Peroxidase 4 (GPx4), Superoxide Dismutase 1 (SOD1), and Superoxide Dismutase
2 (SOD2) were determined using specific antibodies: anti-GPx1 (Prod. No. ab22604; Abcam),
anti-GPx4 (Prod. No. 10005258; Cayman Chemical), anti-SOD1 (Prod. No. ab16831; Abcam)
and anti-SOD2 (Prod. No. ab13533; Abcam). The secondary antibodies used included: goat
anti-mouse IgG horseradish peroxidase (HRP) conjugate (product No. 31430; Pierce
Biotechnology; Rockford, IL) and goat anti-rabbit IgG HRP conjugate (product No. 10004301;
Cayman Chemical). Pierce Enhanced Chemiluminescence Western Blotting substrate (Pierce;
Rockford, IL) was used to detect signal following the manufacturer’s instructions. A G:Box
Bioimaging system (Syngene; Frederick, MD) was used to assess autoradiographic signals.
Data were captured using GeneSnap/GeneTools software (Syngene) and densitometry was
analyzed using Image J Software (National Institutes of Health, Bethesda, MD). Anti-COXIV
rabbit antibody was used as a loading control for mitochondrial protein (product No. #4844; Cell
Signaling Technology).

Glutathione Peroxidase Activity
Total glutathione peroxidase activity was measured spectrophotometrically through the
change in absorbance of NADPH utilizing a commercially available assay (Cayman Chemical,
Prod. No. 703102). In this model, GPx activity is rate limiting allowing us to consider the change
in absorbance as the enzyme activity. The assay was carried out as per manufacturer’s
instructions.
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Statistics
Mean and standard error (SE) were calculated for all data sets. A One-Way Analysis of
Variance (ANOVA) was employed with a Bonferroni post-Hoc test to analyze differences
between treatment groups using GraphPad Prism 5 (GraphPad Software, La Jolla, CA). P <
0.05 was considered significant.
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RESULTS
Cardiac Function Following Nano-TiO2 Inhalation Exposure
While nanomaterial inhalation has implicated cardiovascular dysfunction following
exposure, cardiac functional measures have been limited. In this study we utilized conventional,
pulsed wave Doppler flow and speckle-tracking based strain measures of echocardiography to
thoroughly and sensitively measure cardiac function in vivo following nano-TiO2 inhalation.
Within our study, diametric and spatial parameters identified by M-Mode echocardiography were
not significantly changed with mPHGPx overexpression or following nano-TiO2 inhalation when
compared to control (Table 1). This data suggests that no overt systolic dysfunction is observed
with acute nano-TiO2 exposure.

One common diastolic measure utilizes pulsed wave Doppler flow through the mitral
valve. In this measure, the individual contribution of the passive left ventricle suction during
early diastole (E wave) and the active contraction of the left atria during late diastole (A Wave)
in the refilling of the ventricle can be identified to examine diastolic function through the ratio of
E to A. Following exposure to nano-TiO2, there was a significant increase in the velocity of the E
wave (Figure 2E), yet no change in the A wave velocity was observed (Figure 2F). This change
in E without an accompanying change in A led to an increase in the E/A Ratio (Figure 2G) over
2 following exposure to nano-TiO2 and is indicative of restrictive filling of the left ventricle during
diastole. Deceleration of the mitral valve following exposure was increased (Figure 2H) and
prompts investigation into the effects of nano-TiO2 on the deceleration time of the mitral valve
filling velocity. Deceleration time of early mitral flow, a marker of stiffness routinely measured
during the quantitation of diastolic function, was shortened following exposure to nano-TiO2
further supporting that the heart is stiffer following exposure to nanomaterials (Figure 2I). To
complete our analyses of diastolic function following nano-TiO2 exposure, we normalized
deceleration time to the early filling velocity (E). In humans, this measure has been shown to
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augment the prognostic power of mitral valve tissue Doppler flow indices and predicts heart
failure hospitalization (27). Following nano-TiO2 exposure the normalization of deceleration time
to early filling velocity decreased supporting the conclusion that ENM exposure induces diastolic
dysfunction (Figure 2J). Finally, the diastolic dysfunction observed with nano-TiO2 exposure was
attenuated with overexpression of mPHGPx (Figure 2E-J).

To reinforce the PW-Doppler flow data, we investigated the strain on the heart during
diastole utilizing speckle-tracking based strain echocardiography. Following an acute inhalation
exposure to nano-TiO2, there was a significant increase in the radial strain and strain rate
throughout the wall of the left ventricle (Figure 3A and B). The increased strain and strain rate
further suggest restrictive filling of the left ventricle throughout diastole. Following work that
identified the ratio of the E wave velocity to radial strain rate most closely correlates to the
cardiac catheterization pressures, we investigated this index following nanomaterial exposure.
Our previous data was corroborated as the ratio of E/SR was significantly increased following
exposure (Figure 3C). Overexpression of mPHGPx attenuated the increased speckle-tracking
based strain measures following nano-TiO2 exposure (Figure 3 A-C). This data suggests that
following nanomaterial exposure, the heart has to work harder during diastole to refill and
maintain cardiac systolic function; however, by reducing the impact of ROS through the
overexpression of mPHGPx, we can attenuate the observed diastolic dysfunction.

Spatially-Distinct Mitochondrial Function
Diastole itself is an energy intensive process, and the mitochondria provide the energy
necessary for both contraction and relaxation. Mitochondrial respiratory capacity can be
evaluated by identifying the state 3 and state 4 respiratory rates. Within the cardiomyocyte,
there are two spatially and biochemically distinct subpopulations of mitochondria: the
subsarcolemmal (SSM) which are located below the sarcolemma and the interfibrillar (IFM)
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which reside within the contractile apparatus. Following inhalation exposure, there was no
significant change in either respiratory rate in the SSM (Figure 4A). In contrast, , nanomaterial
exposure decreased the state 3 respiratory rate in IFM suggesting decreased function of the
organelle (Figure 4B). To support the respiratory data we used a spectrophotometric assay to
identify the activity of ATP synthase following nano-TiO2 exposure. Following pulmonary
nanomaterial exposure, no changes were noted in the ATP synthase activity in the SSM (Figure
4C), however, in the IFM there was a significant decrease in the ATP synthase activity (Figure
4D). mPHGPx overexpression rescued the state 3 mitochondrial respiratory rate (Figure 4B)
and the ATP synthase activity (Figure 4D) of the IFM to control levels. This data suggests that
decreased mitochondrial function accompanies cardiac diastolic dysfunction following nano-TiO2
exposure. Also, this data demonstrates that the decreased mitochondrial function observed
following nano-TIO2 exposure is localized to the IFM and treatment with an antioxidant
attenuates the damage.

Mitochondrial Lipid Peroxidation
ROS damage, especially lipid peroxidation, can influence the macromolecule’s function
thus influencing an organelle’s function. We investigated the ROS damage by-products
malondialdehyde (MDA) and 4-hydroxyalkenal (4-HAE) to address the impact ROS have on the
molecules within the mitochondrion. Doing so, we identified that there was a significant increase
in lipid damaged by nano-TiO2 inhalation in the IFM, which was mitigated with overexpression of
mPHGPx (Figure 5B). Again, there was no change in lipid peroxidation within any of the groups
compared to the control in the SSM (Figure 5A). Taken together, this data suggests that ROS
damage within the IFM may contribute to the observed mitochondrial dysfunction following
nano-TiO2 exposure.
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Mitochondrial Hydrogen Peroxide Production
SSM isolated from animals exposed to nano-TiO2 showed no increase in ROS
production (Figure 5C and E). In contrast, there was a significant increase in the hydrogen
peroxide production in IFM following exposure to nano-TiO2 (Figure 5D and F). Overexpression
of mPHGPx was able to attenuate the increased ROS production in the IFM following exposure
(Figure 5D and F). Thus, these data suggest that increased mitochondrial ROS damage in the
IFM following nano-TiO2 exposure may arise from increased mitochondrial ROS production. The
ability of the mPHGPx overexpression to attenuate ROS production suggests that ROS play a
central role in the mitochondrial dysfunction that occurs following nano-TiO2 exposure.

Antioxidant Capacity
In our study, we observed no change in any of the mitochondrial antioxidant enzymes
following exposure to nano-TiO2 in either SSM or IFM (Figure 6A and B). With genetic
overexpression of mPHGPx, we observed a significant increase in the protein concentration of
GPx4 in both SSM and IFM (Figure 6A and B). In addition, by utilizing spectrophotometry and
substrates specific to glutathione peroxidase, we confirmed increased glutathione peroxidase
activity of both SSM and IFM in animals overexpressing mPHGPx (Figure 6C and D). This data
confirms overexpression of mPHGPx was accomplished and that nano-TiO2 did not affect the
antioxidant capacity of the mitochondria.
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DISCUSSION
Nanomaterial commercial incorporation continues to rise, but the impact of these
materials on human health is not fully understood. Inhalation of nano-TiO2 has been shown to
impact cardiovascular function and ROS production within the heart, yet the influence of the
mitochondria on both cardiovascular function and ROS production following acute inhalation
exposure is unexplored. Utilizing our nanomaterial inhalation exposure chamber and a novel
transgenic mouse line overexpressing the antioxidant enzyme mPHGPx, we examined the role
of ROS damage in the cardiac mitochondrial dysfunction and diastolic dysfunction observed
with nano-TiO2 exposure. Our data revealed that acute nano-TiO2 inhalation induces diastolic
dysfunction associated with increased mitochondrial ROS production and metabolic dysfunction
that can be attenuated with overexpression of mPHGPx.

Within this study, we highlight the diastolic dysfunction that occurs after inhalation
exposure to nano-TiO2. While we are not the first to highlight that diastolic function is altered
with exposure to nanomaterials, though we are the first to incorporate speckle tracking based
strain echocardiography to identify this adverse outcome. Previously, Kan et al. identified
decreased diastolic dysfunction following inhalation exposure to nano-TiO2 utilizing pressurevolume loops (22). This supports our data and the use of speckle-tracking based strain
echocardiography as we see a similar end-point. Our lab and others have described the benefit
of this technique in the early identification of cardiac functional defects that precede overt
systolic dysfunction in disease models in both rodent and human analyses (5, 25, 38). Because
this tool is commonly used to identify dysfunction earlier, the dysfunction identified in our acute
model may precede overt dysfunction that may occur in a chronic exposure model.

Diastolic dysfunction is clinically characterized by a decreased rate of LV relaxation and
commonly precedes systolic dysfunction found in many cardiac disorders, such as heart failure.
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By comparing non-invasive speckle-tracking based echocardiographic and invasive cardiac
catheterization indices in humans, Chen et al. was able to isolate the combination of noninvasive parameters that best correlate with diastolic function (9). While they suggested SR by
itself was indicative of LV relaxation, the authors continued that the use of the ratio of E velocity
to SR correlated well with Left ventricular end-diastolic pressure. Our data indicates that
following nano-TiO2 exposure there was an increase in both strain rate and the ratio of E/SR in
the exposed animals. This data supports the use of non-invasive speckle-tracking based strain
echocardiography to identify diastolic dysfunction following nano-TiO2 exposure.

Within the cardiomyocyte, resetting of the cell during diastole to prepare for contraction
is an energy intensive process. Mitochondrial dysfunction has been shown to lead to diastolic
dysfunction in a diabetic model (16), but cardiac mitochondrial dysfunction following nano-TiO2
exposure has not been investigated. Cardiac mitochondrial function following in vivo
nanomaterial exposure is not intensely investigated, but studies have emphasized decreased
mitochondrial function arises following exposure (39). In vitro analyses in a variety of cell types
support the suggestion that decreased mitochondrial function results from exposure to
engineered nanomaterials (28, 43). Thus this manuscript highlights that the mitochondria may
be central in the extrapulmonary impacts following a nanomaterial inhalation exposure.

Previously our lab has identified cardiac mitochondrial dysfunction following exposure to
a regionally specific particulate matter (29). Further, we identified decreased mitochondrial
respiratory rates of both mitochondrial subpopulations that exist in the cardiomyocyte. These
subpopulations are unique both spatially and biochemically. The SSM sit below the
sarcolemma, are larger more variable in size. In contrast, the IFM sit within the contractile
apparatus, are smaller and more compact and have a higher respiratory rate compared to the
SSM. The particulate matter previously investigated was a composite regionally-specific particle
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collected with non-uniform particle size and chemical composition. We then utilized the ENM
MWCNT and compared the effects observed between the composite PM and this uniform ENM.
While the time frames were different, within both of these studies we observed decreased
mitochondrial function. The current studies identifies that the mitochondrial dysfunction
occurring after nanomaterial inhalation is limited to the IFM. Taken together, these studies may
suggest that nanomaterial or the ultrafine fraction of particulate matter may decrease IFM
function, while the larger particle size induces SSM dysfunction. Taking into account these three
data sets, especially the MWCNT, we could assume that this hypothesis is not true, but while
MWCNT are less than 100 nm in one dimension, they can be up to microns in length. Thus the
larger portion of the particle can induce SSM dysfunction while the nano-size particles induce
IFM dysfunction. This hypothesis would be supported by differentially impacted intermediate
mediators following exposure to the particles of different sizes.

In the mitochondria, mPHGPx exists within the inner membrane space primarily at
contact points between the inner and outer mitochondrial membranes. This is important to point
out because it suggests that this antioxidant is especially critical in protecting the lipids and
proteins within these mitochondrial membranes, such as the electron transport chain complex
enzymes. ROS, due to their short half-life, mostly impact the compartment in which they were
produced. In the electron-rich environment near the inner mitochondrial membrane the
probability of ROS formation is increased. Thus, overexpression of a mitochondrial antioxidant
targeted to the inner mitochondrial membrane is likely to prevent mitochondrial dysfunction as
shown by the data within this manuscript. Throughout this study we showed that overexpression
of mPHGPx was able to attenuate cardiac and mitochondrial dysfunction following nano-TiO2
exposure. This data also further suggests ROS as a central component to the cardiac toxicity of
nano-TiO2.
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With respect to the exposure, we have previously reported that this dose is equivalent to
a worker working in the production facility exposed to the current NIOSH recommended
exposure limit of 300 µg/m3 for 40 hours a week for 26 days. This dose has been used within
other animal models and shown to elicit microvascular dysfunction and systemic oxidative
stress (31). The utilization of our novel inhalation facility creates an extremely translationally
relevant exposure model, yet the confirmation of the observed effects in a chronic model would
be of value. Investigation into the effects of acute exposure on cardiac tissue is not without merit
due to the tissues essential function. Acute inhalation exposure has been shown to
expeditiously induce cardiac dysfunction and disrupt subcellular processes such as oxidative
milieu and mitochondrial function (17, 34). While most of these effects have been identified in
particulate matter exposures, the vast majority of literature suggests that nanomaterials are
more toxic than their larger counterparts (33). Thus, the effects observed in this manuscript add
to our limited, current understanding of cardiac mechanisms following nanomaterial exposure.

The exposure concentration used within this study is relevant to an occupational setting,
but due to the rise of nanomaterial incorporation into consumer products and limited pulmonary
elimination, this dose may become relevant to a larger population. The data presented in this
manuscript shows for the first time that ROS production and damage drives mitochondrial
dysfunction, leading to cardiac dysfunction following an acute exposure to nano-TiO2. To
elucidate the importance of ROS in this mechanism we utilized a genetic overexpression of
mPHGPx, which attenuated mitochondrial ROS damage and restored mitochondrial and cardiac
function, highlighting ROS as the driving mechanism of toxicity. Within the disrupted cellular
mechanisms, our study suggests that there is a spatial component to the dysfunction as shown
by differential effects in mitochondrial subpopulations. We propose that this could allude to a
spatial component to the toxicological trigger. Even though this study is specific to nano-TiO2,

174

the nature of this particle could suggest the extrapolation of the observed effects to
nanomaterials in general.
Conclusions
Throughout this article we have outlined the impact of nano-TiO2 on cardiac diastolic
function and the mitochondrial impacts that may contribute to this dysfunction. Utilizing a novel
transgenic animal overexpressing the antioxidant mPHGPx, we support our hypothesis that the
cardiac and mitochondrial dysfunction observed following nano-TiO2 exposure is due to an
increase in mitochondrial ROS production and damage. Our transgenic animal identifies that by
enhancing the antioxidant capacity we can reduce the cardiac and mitochondrial dysfunction
observed following nano-TiO2 exposure.
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Table 4.1
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Table 4.1. M-Mode Echocardiographic Measurements. Values are means ± SE; n = 8 for
each group.
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Figure 4.1
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Figure 4.1. Nanomaterial Inhalation Characterization. (A) Electrical Low Pressure Impactor
(ELPI) count median aerodynamic diameter Dp = 131.6 nm. (B) Titanium Dioxide aerosol mass
concentration throughout the inhalation exposure measured with ELPI. Dashed black line is the
average exposure concentration.
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Figure 4.2
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Figure 4.2. Mitral Valve Pulsed-Wave Doppler Flow. Representative images from pulsedwave Doppler flow through the mitral valve analyses in control (A), nano-TiO2 exposed (B),
mPHGPx (C) and mPHGPx nano-TiO2 exposed (D). Summary data for early mitral valve filling
velocity (E wave) (E) and late mitral valve filling velocity (A wave) (F) in control, exposed,
mPHGPx control and mPHGPx exposed. Ratiometric analysis of E wave velocity to A Wave
velocity in control, exposed, mPHGPx control and mPHGPx exposed (G). Deceleration of early
mitral valve filling velocity (E wave) in control, exposed, mPHGPx control and mPHGPx
exposed (H). Deceleration time of early mitral valve filling velocity (E wave) in control, exposed,
mPHGPx control and mPHGPx exposed (I). Normalization of deceleration time of early mitral
valve filling velocity to the early filling velocity in control, exposed, mPHGPx control and
mPHGPx exposed (J). Values are means ± SE; n = 8 for each group. *P<0.05 for Control vs.
Exposed.
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Figure 4.3
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Figure 4.3. Diastolic Speckle-Tracking Based Strain Analyses. Diastolic radial strain was
analyzed in control, nano-TiO2 exposed, mPHGPx, and nano-TiO2 mPHGPx exposed mice (A).
Diastolic radial strain rate analyzed in control, nano-TiO2 exposed, mPHGPx, and nano-TiO2
mPHGPx exposed mice (B). Analysis of the ratio of early mitral valve filling velocity (E) to radial
strain rate analyzed in control, exposed, mPHGPx, and mPHGPx exposed mice (C). Values are
means ± SE; n = 8 for each group. *P<0.05 for Control vs. Exposed.
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Figure 4.4
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Figure 4.4. Mitochondrial Respiratory Capacity and ATP Synthase Function. Summary
analyses of state 3 and state 4 respiration rates from trace measurements of SSM (A) and IFM
(B) in control, nano-TiO2 exposed, mPHGPx and mPHGPx nano-TiO2 exposed. ATP Synthase
activities were assessed spectrophotometrically by measuring the oxidation of NADH coupled
with pyruvate kinase in SSM (C) and IFM (D) in control, exposed, mPHGPx and mPHGPx
exposed. Respiration rates are expressed in nmol of oxygen·min-1·mg protein-1. ATP Synthase
is expressed as nmol of NADH min-1·mg protein-1. Values are means ± SE; n = 6 for each
group. *P<0.05 for Control vs. Exposed. SSM: subsarcolemmal mitochondria, IFM: interfibrillar
mitochondria.
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Figure 4.5
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Figure 4.5. Mitochondrial Reactive Oxygen Species Production and Lipid peroxidation
by-products. Oxidative damage to lipids was assessed in control, exposed, mPHGPx control
and mPHGPx exposed SSM (A) and IFM (B) subpopulations by measuring lipid peroxidation
by-products malondialdehyde (MDA) and 4-hydroxyalkenal (4-HAE) using a colorimetric assay.
Results were compared against a standard curve of known 4-HAE and MDA concentrations.
Representative plot of hydrogen peroxide production over time in SSM (C) and IFM (D) utilizing
a fluorescent dye activated by hydrogen peroxide. Solid lines represent control exposure and
dashed lines represent nano-TiO2 exposure. Black lines represent control mice, while grey lines
represent mPHGPx mice. Summary data of hydrogen peroxide production expressed as change
in fluorescence min-1·mg protein-1 for SSM (E) and IFM (F). Values are expressed as means ±
SE. n = 8 per each group. *P < 0.05 for Control vs. Exposed. SSM: subsarcolemmal
mitochondria, IFM: interfibrillar mitochondria.
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Figure 4.6

194

Figure 4.6. Mitochondrial Antioxidant Capacity. Relative protein content assessed by
Western blotting of mitochondrial antioxidant enzymes. Representative Western blots for
glutathione peroxidase 1 (GPx1), glutathione peroxidase 4 (GPx4), superoxide dismutase 1
(SOD1) and superoxide dismutase 2 (SOD2) in SSM (A) and IFM (B). All Western blots were
normalized to cytochrome c oxidase (COXIV) for analysis. n = 6 for each group. Total
mitochondrial glutathione activity was assessed utilizing spectrophotometry in SSM (C) and IFM
(D). *P<0.05 for Control vs. Exposed. SSM: subsarcolemmal mitochondria, IFM: interfibrillar
mitochondria.
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GENERAL DISCUSSION
The overall objective of this dissertation was to determine the impacts of an acute
xenobiotic pulmonary exposure on cardiac and mitochondrial function. Specifically, we wanted
to [1] to elucidate the impact a regionally-specific particulate matter pulmonary exposure has on
cardiac apoptosis and mitochondrial dysfunction [2] to investigate the influence of a pulmonary
exposure to carbon-based engineered nanomaterials on mitochondrial oxidative stress and [3]
to evaluate the impact ROS damage plays in cardiac and mitochondrial dysfunction following a
pulmonary exposure to an ENM using a mitochondrial antioxidant (mitochondrial phospholipid
hydroperoxide glutathione peroxidase; mPHGPx). Our long-term goal is to better understand
the impacts of xenobiotic exposure in order to understand how they may contribute to
cardiovascular disorders. The central hypothesis of this dissertation was that acute pulmonary
exposure to particulates of varying size and chemical composition differentially elicits increased
cardiac oxidative stress triggering apoptosis and eliciting cardiac mitochondrial dysfunction,
which is subject to spatial influence, contributing to cardiac dysfunction following exposure. My
rationale for the proposed research was based on the finding that particulate matter increases
cardiac susceptibility and increased mortality from chronic cardiovascular disease. Also, this
research was based on the findings that mitochondria may be targets of engineered
nanomaterial exposure. I anticipated being able to determine the mechanisms impacting cardiac
and mitochondrial function following acute xenobiotic exposure to particles of different size and
chemical composition. The outcomes provided insight into the role of ROS in mitochondrial
mechanisms impacting the cardiovascular system following an acute pulmonary xenobiotic
exposure.
Adverse cardiovascular outcomes of acute pulmonary xenobiotic exposure have been
identified but the mechanisms contributing to these outcomes are not well defined. Short-term
exposure to ambient PM has been associated with increased acute cardiovascular mortality in
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humans (7). Animal models support the cardiovascular disruption and deliver potential
mechanisms contributing to the increased mortality (6). Importantly, particulate chemical
composition varies regionally due to variations in particle sources (17), and this composition
may play a role in the different health outcomes that are observed following exposure (82).
Particle size also varies significantly within a translational, composite particle such as PM:
ranging from large micron-sized particles (PM10 and PM2.5) to smaller nano-sized particles
(UFP). Previous studies have shown that smaller PM particles have greater cardiovascular
effects when compared to larger particles (6, 47, 63). While these UFP are similar in size to
ENMs they not only differ in intention but also in composition. ENMs are materials created
intentionally through precise procedures with relatively uniform size and composition; while,
UFP are mostly by-products of combustion and heterogeneous in size and chemical
composition. Thus, particle size and chemical composition may be able to induce differential
toxic endpoints.
Adverse cardiovascular events have been identified in a number of particle exposures
(7). The mechanisms proposed to induce these adverse outcomes vary between exposures, but
ROS production and damage are commonly implicated in xenobiotic toxicity (49). Within the
cell, reactive oxygen species are predominantly derived as a by-product of oxidative
phosphorylation within the mitochondria. Studies indicate the mitochondrion may be implicated
in the toxicity associated with xenobiotic exposure: highlighting mitochondrial dysfunction,
increased ROS production, and mitochondrial apoptotic signaling following exposure (90).
Mitochondria have been identified as central in the etiology of cardiac pathology, but their
impact in the cardiovascular dysfunction observed following xenobiotic exposure has not been
investigated. Cardiac mitochondrial studies are further complicated by the presence of two
spatially and biochemically distinct subpopulations of mitochondria. These mitochondrial
subpopulations differentially respond to physiological and pathological stimuli. The studies
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within this dissertation suggest that cardiac mitochondrial subpopulations may be differentially
affected following xenobiotic exposure.
To begin to investigate the impact of particle size and composition on cardiac and
mitochondrial function, I first began by investigating the endpoints of exposure to PM from
ambient air pollution surrounding active MTM sites. Utilizing conventional echocardiography
following exposure to PMMTM there was a significant decrease in the end-systolic volume and
diameter but no change in the end-diastolic volume or diameter leading to a significant decrease
in fractional shortening and ejection fraction. This data suggests that the cardiac function was
decreased following exposure to PMMTM. Concomitant with the decreased function was an
increase in cardiac apoptosis with mitochondrial apoptotic signaling increased. The
mitochondrial signaling was supported by an increased mPTP opening propensity. While the
apoptotic propensity was highest in the SSM, both the SSM and IFM exhibited decreased
maximal respiratory rates following exposure suggesting mitochondrial dysfunction induced by
PMMTM. Taken together, this data illustrates that acute pulmonary exposure to PMMTM induces
cardiac contractile dysfunction and mitochondrial dysfunction, most pronounced in the SSM.
We next sought to understand the impact of acute pulmonary ENM exposure on cardiac
and mitochondrial function utilizing MWCNT. Further, we applied two different MWCNT doses
and time points to identify the effect of dose and time on cardiac and mitochondrial endpoints.
Following exposure we identified subclinical cardiac disturbances as measured by the novel
speckle-tracking based echocardiography. Yet the responses observed 24 hours post-exposure
were not dose dependent. Mitochondrial impacts were observed four hours following exposure
exhibiting decreased maximal mitochondrial respiration in both the SSM and IFM. Twenty-four
hours following exposure the observed decrease in mitochondrial respiratory rate was restored
to control levels except in the IFM of animals exposed to the lower MWCNT dose. Finally, we
investigated ROS production and damage following MWCNT exposure, and identified increased
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ROS production and damage in the IFM 24 hours following exposure. This study suggests that
carbon-based ENM exposure induced mitochondrial dysfunction and ROS production, with the
IFM most impacted.
ROS is commonly implicated in studies of both xenobiotic exposure and the
mitochondrion independently, thus we wanted to investigate the role of mitochondrial ROS in
the extrapulmonary toxicity of ENM exposure. In order to accomplish this goal, we utilized a
novel transgenic animal, developed within our laboratory, overexpressing the mitochondrial
antioxidant mPHGPx and WVU’s unique nanomaterial inhalation chamber to expose these
animals to the relatively inert ENM, nano-titanium dioxide. Following nano-TiO2 exposure, we
observed diastolic dysfunction as indicated by an increase in pulsed-wave Doppler flow indices
as well as increased cardiac strain as measured by speckle-tracking based echocardiography.
Yet, the diastolic dysfunction observed with exposure was attenuated with overexpression of
mPHGPx. We then assessed mitochondrial dysfunction and observed a decrease in the
maximal respiratory rate of the IFM following nano-TiO2 exposure, and that was attenuated with
overexpression of mPHGPx. Finally, we investigated mitochondrial ROS production and
damage following nano-TiO2 exposure and recognized a significant increase in both production
and damage in the IFM. Both indices were attenuated with overexpression of mPHGPx;
supporting that mPHGPx can protect the heart from xenobiotic indiced damage. This data
indicates that acute pulmonary exposure to nano-TiO2 induces diastolic dysfunction concomitant
with mitochondrial ROS production and dysfunction in the IFM.
Taken together, this data suggests that xenobiotic particle size and/or chemical
composition can impact the extrapulmonary outcomes of an acute pulmonary exposure.
Throughout this dissertation we have utilized particles with varying sizes. In the ambient PM
(PMMTM) the particle is translational, as it was taken from areas surrounding active MTM mines.
Yet this means that the exposure particle is a composite particle encompassing a range of
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sizes. The heterogeneity of the particle makes discussions on the specific particle
characteristics responsible for extrapulmonary toxicity difficult. Yet when we compare this
heterogenous particle with our homogenous ENMs we can then begin to theorize on the impact
size plays. We see differential cardiac and mitochondrial effects between all of the examined
particles. In the ambient PMMTM our impacts were observed in the SSM and the IFM, yet many
indices pointed to a more significant SSM effect. In the MWCNT again both the SSM and IFM
were functionally impaired but ROS generation and damage was highlighted in the IFM alone.
Finally, nano-TiO2 exposure only impacted the IFM function and oxidative potential. Considering
size alone, this data would suggest that larger particles induces pulmonary and extrapulmonary
mechanisms that contibute to functional dysfunction in the SSM, yet smaller, nano-sized
materials stimulate mechanisms contributing to IFM dysfunction.
This theory stems from the fact that there is a fraction of the PM used within this
dissertation that is within the same size fraction as ENMs. Thus the IFM dysfunction induced by
PMMTM exposure would arise from the mechanisms stimulated by this UFP fraction and the SSM
dysfunction is induced by the remaining larger fractions. Taking into account the SSM
dysfunction observed with MWCNT exposure challenges this theory, but while MWCNTs fit the
definition of nanomaterial, as the width of the tubes is less than 100 nm, the tubes are microns
in length and agglomerate. Thus again in this exposure the particle size may stimulate
mechanisms leading to both SSM and IFM dysfunction, yet because the MWCNT are of nanosize, IFM effects were predominant. Finally, the nano-TiO2 is the most straightforward as its
primary particle size is a nanoparticle in every dimension and best fits the definition. The data
from our exposure supports that the nano-size is able to induce IFM dysfunction as this was the
only subpopulation impacted by nano-TiO2 exposure. This data suggests that particle size can
differentially impact toxicological impact, but further suggests that size alone doesn’t dictate
effect.
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When considering nanomaterial size and physiochemical properties many studies utilize
surface area to compare the biological impacts of ENM exposure. It has been suggested that
normalization to surface area is a better predictor of bioactivity than mass or size (54, 67). As
we observed in Figure 1.1A the surface area of nano-sized particles in the same particle mass
is significantly higher than in micron sized particles. The PM studied within this dissertation
contains a mixture of micron and nano-sized particles, and without thorough particle
characterization the exact surface area isn’t known. We can estimate that the surface area is
lower in reference to our other particles, and other studies utilizing ambient PM have recorded
the surface area of their material. Depending on the filter that was used, one study from
Portland, Oregon reported the surface area of their material between 0.82 and 2.4 m2/g (71).
Estimating the surface area of CNT is also difficult and depends on the number of walls within
the particle. A theoretical estimation of CNT surface area identified a very broad range, from 50
to 1315 m2/g, again depending on the number of walls (61). Finally, with a primary particle size
of 21 nm nano-TiO2 has a surface area of 48.08 m2/g (52, 76). Considering our data in this
context, the lower surface area particle primarily impacted the SSM and the higher surface area
particles significantly effected the IFM. And while the theory is not complete simply considering
surface area, combining surface area and size helps to delineate the particle characteristics that
impact mitochondrial subpopulation response. Thus, this evidence builds on the theory that the
particle’s physical properties dictate toxicological impact but suggests that size and surface area
need to be considered.
Of course size and surface area are not the only difference between the particles, as the
chemical composition varies throughout the particle utilized in this dissertation. The ambient
PMMTM used in Chapter 2 had a heterogenous chemical composition which was high in carbon,
silicon and sulfate with traces of metals such as aluminum and iron (37). Previoulsy we have
discussed the sizes within ambient PM and related the UFP fraction to ENMs, yet it is important
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to point out the significant differences in composition between these particles. Ambient UFP are
heterogenous in size, aggregation state and chemical composition. These particles are
generally from combustion sources and include a solid core of either inorganic material or soot
surrounded by a layer of absorbed or condensed semi-volatile organic chemicals (66). In
contrast, the ENMs utilized within these studies were homogenous. The MWCNTs used were
greater than 99 percent carbon and the greatest deviance within the TiO2 was the mineral form
(80% anatase and 20% rutile). The easiest comparison is between the PMMTM and MWCNT as
they are both comprised mainly of carbon. Interestingly, exposure to these carbon-based
materials induced both SSM and IFM functional deficiencies suggesting that exposure to
particles high in carbon may induce cardiac mitochondrial dysfunction. Both PM (41) and CNT
(85) have been shown to induce mitochondrial dysfunction thus our results are in accordance
with previous examination. Previous study has suggested that carbon nanomaterials and
titanium dioxide can induce similar endpoints through different mechanisms (33). The data
within this dissertation agrees with this study as we observed similar mitochondrial endpoints in
both the MWCNT and nano-TiO2 exposure. Combined, these studies make it difficult to speak to
the influence of chemical composition on the observed mitochondrial toxicological impacts as
they are similar and in accordance with literature but spatially divergent.
As with most acute exposures we observed significant impacts but it is difficult to
determine the longevity of these impacts and their impacts on chronic disease. The PM MTM dose
used is similar to a 1.7 year exposure but given in a matter of seconds. Also, both doses of
MWCNT would require exposure over years to reach the exposures utilized in these studies.
MWCNT occupational exposures at typical 10 µg/m3 would require 19 years of exposure in
humans to achieve the pulmonary deposition of even the lowest MWCNT dose (22). The nanoTiO2 dose was utilized as previous studies have identifued cardiovascular impacts and is an
occupationally relevant dose similar to a human working eight hours per day at the National
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Institute for Occupational Safety and Health current recommended exposure limit for nano-TiO2
(0.3 mg/m3) for approximately one week. Yet with our increasing understanding of nanomaterial
impacts this dose could still be considered high. This dosen’t decrease the importance of these
studies as acute exposures still occur and acute PM effects are well established (7, 64). We do
need to consider the possibility that the observed effects are due to a bolus effect and with
chronic exposures we may see different effects or adaptations rectifying the acute effects that
are observed in our studies.
Throughout the time course in the MWCNT exposure we observed a significant increase
in the myoglobin concentration and suggested that this could be an adaptation to protect the
mitochondria from dysfunction. Myoglobin is increased in response to hypoxia (25) and the
combination of work and hypoxia may further stimulate an increase in myoglobin (35, 88).
Previously exposure to CNT stimulated hypoxia and mitochondrial dysfunction not only
suggesting nanomaterials can induce hypoxia but that mitochondrial dysfunction and hypoxia
are associated following particulate exposure (85). Intracellular hypoxia can arise from
insufficient oxygen delivery occurring either by decreased pulmonary oxygen loading or
decreased deliver to the tissue. Pulmonary dysfunction following chronic MWCNT exposure has
been identified (86) but in an acute model is highly unlikely. However, impaired coronary
microvascular function following MWCNT exposure may suggest decreased delivery of blood
and oxygen to the tissue may occur within 24 hours post-exposure and persists through 168
hours (75). While we did not experimentally investigate hypoxia in this MWCNT exposure model
taken together these studies suggest acute hypoxia may follow exposure and could induce the
observed mitochondrial effects. Further, because we observed similar mitochondrial impacts in
following nano-TiO2 exposure, it is interesting to discuss that similar coronary microvascular
impacts have been identified following TiO2 exposure (40). Thus, this could suggest that
nanomaterials can induce acute cardiac hypoxia as a shared exposure impact.
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Pulmonary impacts leading to extrapulmonary effects are identified but subcellular
mechanisms that induce cardiac dysfunction are not well characterized. Throughout this
dissertation we highlight cardiac and mitochondrial dysfunction. In pathological models
mitochondrial dysfunction precedes muscle dysfunction suggesting that the mitochondrial
dysfunction elicits tissue dysfunction (21, 44). In our studies, mitochondrial dysfunction is
concomitant with cardiac dysfunction making discussion of the relationship between cause and
consequence difficult. As previously stated cardiac dysfunction can shadow mitochondrial
dysfunction. The mitochondria are essential, yet complex, organelles that not only provide the
cell with ATP but also synthesize key molecules, buffer calcium gradients and are a source of
free radicals. Sub-organelle dysfunction initiation is difficult to assess in vivo, but in vitro
analyses have suggested increased ROS production precedes mitochondrial dysfunction (10,
77). ROS is commonly increased in exposure models (8, 43) and could suggest that systemic
ROS contributes to increased mitochondrial ROS production leading to mitochondrial
dysfunction. Inversely, one study suggests that mitochondrial dysfunction can precede ROS
production in pulmonary tissue suggesting in our study mitochondrial dysfunction may initiate
ROS production (50). Our time course study of the impacts of MWCNT suggests mitochondrial
dysfunction precedes ROS production, but within the other particle exposures we cannot speak
to which is the subcellular stimulus and which is the response. Yet considering our data, we
suggest that xenobiotic exposure induces mitochondrial dysfunction leading to increased ROS
production.
Combining our data and previous literature it is most likely that mitochondrial dysfunction
contributes to cardiac dysfunction, but it could also be suggested that cardiac dysfunction could
contribute to mitochondrial dysfunction. The mitochondrion is a complex organelle and receives
significant input from the nucleus and cytoplasm. Especially within the cardiomyocyte, the
exchange of ions, such as calcium, is important for the function of the cell but mitochondrial ion
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handling can impact the organelle’s function and apoptotic propensity (55). The cardiovascular
system is a highly integrated system regulating and assimilating global pump function,
neurohormonal status, vascular properties and systemic hemodynamics. Alteration in any of
these components elicits a response in the others to maintain output; in fact, this occurs so
predictably that computational models have been developed and curated to estimate
cardiovascular adaptations (36). Thus, as seen in hypertension, when blood pressure increases,
vascular properties are supplemented to compensate for the pressure and global pump function
is altered by increasing pumping strength to overcome the vascular pressure and maintain
tissue oxygen delivery. Further, hypertension has been shown to stimulate cardiac
mitochondrial dysfunction and ROS production (18, 31). As previously discussed, vascular
impairment has been characterized following ENM (40, 75) and PM (53) exposure; thus, cardiac
adaptations could arise as compensatory mechanisms to overcome vascular impairments.
These adaptations may result in the induction of mitochondrial dysfunction from cardiovascular
disruptions. Yet, in Chapter 3 following MWCNT exposure, we observed cardiac dysfunction
follows mitochondrial dysfunction; thus, this data supports that mitochondrial dysfunction
contributes to cardiac dysfunction. Yet without different time points we cannot confirm this timecourse in other exposure models.
Mitochondrial defects, systemic inflammation, and oxidative stress are central to most
noncommunicable diseases such as cancer, atherosclerosis, neurodegenerative diseases,
heart and lung disturbances, diabetes, and autoimmune diseases (2, 21, 38, 45, 56-58). During
xenobiotic exposures oxidative stress and systemic inflammation are identified (29, 62, 80), and
throughout this dissertation we suggest that mitochondrial defects are also present following
exposure. Thus, it is of utility to compare the mitochondrial impacts observed in our study to the
mitochondrial effects during pathology. In Chapter 1, we discussed in detail the differential
impacts of pathological stimuli on mitochondrial subpopulations, but some of the discussed
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effects are more applicable to the effects observed. Like the studies in this dissertation, some
pathologies impact both subpopulations but the effects are most prevalent in one subpopulation.
Ischemia/reperfusion injury leads to increased mitochondrial ROS, apoptosis initiation, and
mitochondrial dysfunction (5, 74), but when we distill out the phases of this injury we see
differential effects. During ischemia alone the SSM are predominantly affected (9, 73), and,
taken together, these studies may relate to the results observed following PMMTM exposure.
Initially the impacts are observed in both SSM and IFM but apoptotic propensity is most
impacted at the SSM. This may suggest changes in oxygen concentration stimulate the more
preferentially SSM phenomenon as larger changes in oxygen tension are more likely to be
experienced by the SSM as compared to IFM (32). Further, this could be applied to the SSM
changes observed following MWCNT exposure, and builds on the importance of changes in
oxygen tension following xenobiotic exposure.
Conversely, oxygen tension in the center of the cell is much less than at the cell
periphery (79), and hypertrophic conditions stimulated by pressure overload more negatively
impact the IFM (70). This data may support the studies included within this dissertation that
utilize ENMs as they most impacted the IFM, and would suggest decreased oxygen tension
following ENM exposure. Further, the increased myoglobin content following MWCNT exposure
could support this theory as decreased oxygen tension stimulates myoglobin production (23).
However, without the scientific evidence to directly implicate oxygen tension it is unrealistic to
assign causality. To date, there are no studies manipulating oxygen tension and investigating
the impacts on mitochondrial subpopulations, but a three-dimensional computational
cardiomyocyte model that integrates electrophysiology, metabolism, and mechanics with
subcellular structure and further includes intracellular oxygen diffusion in order to determine
whether mitochondrial localization or intrinsic properties cause functional variations. Utilizing this
model the authors suggested that under limited oxygen supply, oxygen is mostly exhausted in
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SSM, leaving the core region in an anoxic condition leading to a decrease in inner membrane
potential in the IFM (30). Acute changes in oxygen tension can decrease mitochondrial
respiration by up to 50% and as a compensatory mechanism stimulate hydrogen peroxide
production (16). This could support that decreased oxygen tension can differentially impact the
IFM and elicit the results observed following exposure to the ENMs, MWCNT and nano-TiO2.
Interestingly, cardiovascular complications and heart disease are the leading cause of
morbidity and mortality in patients with diabetes mellitus, and mitochondrial dysfunction is
central to the pathogenesis of these complications (24). Diabetes mellitus is characterized by
either a lack of insulin (Type 1) or resistance to insulin (Type 2), and there are differential
mitochondrial subpopulation impacts during these disease states. During type 1 diabetes the
IFM are preferentially impacted: exhibiting increased ROS production (13), increased apoptotic
propensity (87) and dysregulated proteomics (3). While in type 2 diabetes the SSM are
preferentially affected: exhibiting increased ROS production and dysregulated proteomics (12).
Interestingly, the effects observed in a mouse model of type 2 diabetes directly correlate to the
effects observed in the human suggesting that mouse models are sufficient predictors of human
mitochondrial function (11). Even though both pathologies impart similar deleterious effects on
the mitochondria, the resulting milieus are different. These differential effects suggest that
different stimuli can elicit similar mitochondrial end-points. Also, this highlights that disparities in
the developed stress elicits differential subcellular locale influences, including the mitochondria
contained within.
Systemic effects following a pulmonary exposure have been identified and linked to
extrapulmonary impacts. Yet these systemic effects can vary between exposures and may
include inflammation (20), particle translocation (19) and circulating bioactive factors (1). Within
our exposures we did not experimentally investigate the systemic stimuli leading to
extrapulmonary effects, but evidence most supports inflammation to lead to these impacts (39,
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48). Especially in an acute setting, the quick response of inflammation to xenobiotic particulates
suggests inflammation can play a role in the exposures observed throughout this dissertation.
Therefore exposing an animal with suppressed inflammation to xenobiotic particulates would
elicit an attenuated response as this is carrying the signals from the lung to the systemic
circulation. Yet recent evidence supports that circulating bioactive factors can impact the
cardiovascular system even in naïve tissue (1). When the authors knocked out matrix
metalloproteinase-9 the cardiovascular effects of these factors were attenuated suggesting
decreased production of bioactive factors and significantly implicating these factors in the
initiation of cardiovascular effects (1). Yet systemic effects may not directly dictate end point, as
MWCNTs with different physiochemical properties induce similar systemic effects but different
tissue responses (65). Thus, it is interesting to identify the differential systemic stressors in each
particle exposure in order to better understand the differential cardiac and mitochondrial impacts
observed, but may not definitively transcribe into other exposure models.
Because we are investigating extrapulmonary impacts of a pulmonary exposure we can
safely assume that signals are being generated at the lungs and transmitted to extrapulmonary
tissue. Pulmonary effects such as increased alveolar permeability and inflammation are well
characterized, but very rarely is decreased pulmonary function identified in translationally
relevant models of xenobiotic exposure. Yet, cardiovascular effects are commonly identified (7)
suggesting either systemic effects are more specific to the cardiovascular system or the
cardiovascular system is more sensitive to these stressors. In fact, one study comparing
pulmonary and cardiac effects concluded that the heart is more susceptible to the oxidative
effects induced by xenobiotic exposure (15). Further these authors suggest that the oxidative
damage mediated by hydrogen peroxide may be involved in the cardiac toxicity related to PM
exposure (15). Highly metabolic demanding tissues as a whole may be preferential targets of
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xenobiotic toxicity and further suggest the disruption of the oxidative milieu as central to the
etiology of dysfunction (68).
Throughout this dissertation we highlight that the cardiac mitochondria are impacted
following xenobiotic exposure, but the direct mechanisms leading to these effects are transiently
discussed.

As

previously

discussed,

systemic

inflammation

most

likely

champions

extrapulmonary effects and a common mechanism utilized by inflammatory cells is ROS.
Systemic ROS after xenobiotic exposure follows systemic inflammatory increases and as
previously discussed cardiac tissue may be more sensitive to ROS damage (15). Increased
ROS damage within the heart helps to explain cardiac functional deficiencies as proteins
damaged within the contractile apparatus cannot function as well (4). But differential ROS
damage within cardiac mitochondrial subpopulations can begin to explain the differential
responses observed following xenobiotic exposure. Due to the location of the SSM, beneath the
sarcolemma, and the dysfunction observed following exposure this could support that the initial
insult is carried out through inflammation and moves from outside of the cell into the interior.
Taken together with the observation that the SSM may have a higher antioxidant profile (32) this
could support that ROS damage moving through the cell can lead to dysfunction in both
subpopulations with a larger insult or only the IFM when the ROS damage can be handled by
the antioxidants within the SSM. Thus the ROS signal created within the lung can permeate to
the heart and induce mitochondrial dysfunction but may more frequently lead to IFM
dysfunction.
Within the mitochondria there are sub-organelle locales that may also be differentially
impacted by ROS. Due to the unstable, radical nature of ROS, the molecules have a short halflife and the sites of origin are most susceptible to damage by these molecules. ROS are most
produced as by-products of electron exchange by NADH dehydrogenase (complex 1) and
cytochrome c reductase (complex 3) within the IMM of the mitochondrion (78, 81). Thus the IMM
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and the proteins and lipids that reside within the membrane are most susceptible to ROS
damage. This situation suggests that protecting the IMM may be critical in maintaining
mitochondrial dysfunction during increased ROS production. MPHGPx is a unique antioxidant
as it can reduce free ROS species and their lipid peroxidation by-products. Also it is located
within the IMS and capable of preserving the integrity of the membrane by protecting against
ROS-mediated dysfunction (3, 14, 51). Following ENM exposure, we suggested that mPHGPx
was able to protect the mitochondria from dysfunction; implicating ROS in the induction of
dysfunction and reiterating the protective capabilities of mPHGPx. Ultimately, mPHGPx was
also able to restore cardiac function supporting the importance of not only mPHGPx but also
protecting the IMM from ROS damage.
Finally, as cardiac function is the functional implication indicated in each study
discussion into the relative impacts is critical in this dissertation. The most straightforward
impacts are observed in the PMMTM exposure: decreased end-systolic volumetric and diametric
parameters leading to decreased ejection fraction and fractional shortening. Yet no changes in
cardiac output were observed illustrating increased cardiac stress but ultimately maintaining
cardiac function. This is relevant to other animal studies (26, 89) and indicative of human PM
exposures, in which cardiac remodeling without cardiac dysfunction is detected indicative of
increased stress (83). With the recent advent of nanotechnology there are no human studies
identifying ENM induced cardiac functional deficiencies. Functional analyses following animal
exposures to MWCNT and nano-TiO2 are limited but suggest disturbances (34, 91). Following
nano-TiO2 exposure our results emulate these studies identifying diastolic dysfunction, but in
our study we utilized speckle-tracking based echocardiography as a sensitive marker of cardiac
function. This data suggested the heart may be stiffer following exposure. Taken together with
the mitochondrial dysfunction observed, this supports that the resetting of the contractile
apparatus and calcium currents during diastole is an energy intensive process. Thus
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mitochondrial dysfunction correlates with both systolic and diastolic function. Speckle-tracking
echocardiography is already being utilized clinically to subtly detect cardiac functional
abnormalities earlier in diabetes (72), myocardial ischemia (84), and non-ischemic
cardiomyopathies (42) and prediction of patient outcomes with heart failure (28). Thus, utilizing
this technique may allow clinicians to detect cardiac abnormalities associated with exposure to
ENMs and include exposure as a risk factor for cardiovascular dysfunction.
While speckle-tracking based strain analyses are already clinically used as an early
predictor of cardiac abnormalities, the mechanical and biochemical mechanisms that contribute
to changes in strain have not been investigated. As discussed in chapter 1, strain is a
complicated measure that, while we use it to discuss cardiac function, is most tightly correlated
with cardiomyocyte contractility and relaxation. Relating to both contractility and relaxation are
the proteins of the contractile apparatus. Posttranslational modifications induced by ROS
damage to the contractile apparatus can impair the function of the cardiomyocyte implicating
ROS to induce changes in strain values (27, 46). Yet also, of mention in relation to the function
of the contractile apparatus and thus the cardiomyocyte is calcium regulation. While calcium
currents are most regulated by the sarcoplasmic reticulum, the mitochondrion also plays a large
role in calcium handling. Calcium within the mitochondria is a mediator of metabolic and
pathological processes (69), but calcium handling also differs between mitochondrial
subpopulations and suggests that the IFM are more sensitive to changes in calcium (59, 60).
Thus changes in calcium may be able to regulate mitochondrial function and impact
cardiomyocyte contractility. Also taken together, with the data in this dissertation, implicates
cardiac calcium dysregulation following xenobiotic exposure suggesting that ENM exposure
especially induces calcium dysregulation leading to impaired contractility, as indicated by
changes in the speckle-tracking based strain profile, and mitochondrial dysfunction most
pronounced in the IFM.
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The overall summary of this dissertation identifies cardiac and mitochondrial dysfunction
following acute pulmonary xenobiotic exposure. Examining cardiac function following exposure
to ambient PM taken from areas surrounding active MTM sites (PMMTM) suggested decreased
cardiac function indicated by decreased ejection fraction and fractional shortening. Investigating
the mechanisms that could induce this result, we identified increased cardiomyocyte apoptosis
from a mitochondrial source. The mitochondrial apoptotic signaling was suggested to be most
pronounced in the SSM with increased apoptotic propensity suggested by increased opening of
the mPTP in this subpopulation. Yet mitochondrial respiratory function was decreased in both
the SSM and IFM, suggesting that PMMTM exposure stimulates mitochondrial impacts with the
SSM being unequally impacted. Yet due to the heterogeneous nature of the ambient particle we
wanted to use a homogenous material to distill the effect of size on cardiac and mitochondrial
impacts. Utilizing a well-characterized MWCNT, we identified that exposure induces notable
impacts. These cardiac aberrations were concomitant with increased mitochondrial ROS
production and damage in the IFM, and these mitochondrial effects followed mitochondrial
dysfunction acutely observed post-MWCNT exposure in both the SSM and IFM. This data
suggests that ENMs induce mitochondrial effects, most pronounced in the IFM, which may lead
to decreased cardiac function. We then wanted to investigate the role of ROS in the induction of
mitochondrial and cardiac dysfunction following ENM exposure. In order to accomplish this we
used the mitochondrial antioxidant mPHGPx and the abundant ENM, nano-TiO2. Following
exposure we identified cardiac diastolic dysfunction concomitant with increased mitochondrial
ROS production and damage in the IFM. This increased ROS damage led to decreased IFM
respiratory function. By overexpressing a mitochondrial antioxidant we could attenuate the ROS
production and damage to the IFM. Attenuating ROS damage alleviated the identified IFM
dysfunction and further diminished the diastolic dysfunction created by nano-TiO2 exposure.
This suggests that ROS plays a significant role in the cardiac and mitochondrial dysfunction
observed following ENM exposure. Taken together these studies identify that cardiac
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dysfunction is initiated by acute pulmonary exposure to xenobiotic particles, and particle size
and surface area may regulate toxic endpoint. Further, this dysfunction may arise from
increased mitochondrial ROS leading to mitochondrial dysfunction that may have a spatial
aspect.
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